BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sun B, Karin M. Obesity, inflammation, and liver cancer. J Hepatol. 2012;56:704-713. [PMID: 22120206 DOI: 10.1016/j.jhep.2011.09.020] [Cited by in Crossref: 284] [Cited by in F6Publishing: 267] [Article Influence: 25.8] [Reference Citation Analysis]
Number Citing Articles
1 Li BL, Hu JJ, Xie JD, Ni C, Liang HJ, Li QR, Yuan J, Wu JW. Rosanortriterpenes A-B, Two Promising Agents from Rosa laevigata var. leiocapus, Alleviate Inflammatory Responses and Liver Fibrosis in In Vitro Cell Models. Evid Based Complement Alternat Med 2020;2020:8872945. [PMID: 33224259 DOI: 10.1155/2020/8872945] [Reference Citation Analysis]
2 Wang Q, Yu WN, Chen X, Peng XD, Jeon SM, Birnbaum MJ, Guzman G, Hay N. Spontaneous Hepatocellular Carcinoma after the Combined Deletion of Akt Isoforms. Cancer Cell 2016;29:523-35. [PMID: 26996309 DOI: 10.1016/j.ccell.2016.02.008] [Cited by in Crossref: 60] [Cited by in F6Publishing: 62] [Article Influence: 10.0] [Reference Citation Analysis]
3 Cheuk-fung Yip T, Wai-sun Wong V, Lik-yuen Chan H, Tse Y, Pik-shan Kong A, Long-yan Lam K, Chung-yan Lui G, Lai-hung Wong G. Effects of Diabetes and Glycemic Control on Risk of Hepatocellular Carcinoma After Seroclearance of Hepatitis B Surface Antigen. Clinical Gastroenterology and Hepatology 2018;16:765-773.e2. [DOI: 10.1016/j.cgh.2017.12.009] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 5.0] [Reference Citation Analysis]
4 Tili E, Michaille J, Croce CM. MicroRNAs play a central role in molecular dysfunctions linking inflammation with cancer. Immunol Rev 2013;253:167-84. [DOI: 10.1111/imr.12050] [Cited by in Crossref: 151] [Cited by in F6Publishing: 144] [Article Influence: 16.8] [Reference Citation Analysis]
5 Phillips CL, Grayson BE. The immune remodel: Weight loss-mediated inflammatory changes to obesity. Exp Biol Med (Maywood) 2020;245:109-21. [PMID: 31955604 DOI: 10.1177/1535370219900185] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
6 Amini N, Ejaz A, Spolverato G, Maithel SK, Kim Y, Pawlik TM. Management of Lymph Nodes During Resection of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma: A Systematic Review. J Gastrointest Surg 2014;18:2136-48. [DOI: 10.1007/s11605-014-2667-1] [Cited by in Crossref: 56] [Cited by in F6Publishing: 54] [Article Influence: 7.0] [Reference Citation Analysis]
7 Piguet A, Saran U, Simillion C, Keller I, Terracciano L, Reeves HL, Dufour J. Regular exercise decreases liver tumors development in hepatocyte-specific PTEN-deficient mice independently of steatosis. Journal of Hepatology 2015;62:1296-303. [DOI: 10.1016/j.jhep.2015.01.017] [Cited by in Crossref: 59] [Cited by in F6Publishing: 57] [Article Influence: 8.4] [Reference Citation Analysis]
8 Uddandrao VVS, Rameshreddy P, Brahmanaidu P, Ponnusamy P, Balakrishnan S, Ramavat RN, Swapna K, Pothani S, Nemani H, Meriga B, Vadivukkarasi S, P. R. N, Ganapathy S. Antiobesity efficacy of asiatic acid: down-regulation of adipogenic and inflammatory processes in high fat diet induced obese rats. Archives of Physiology and Biochemistry 2020;126:453-62. [DOI: 10.1080/13813455.2018.1555668] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
9 Guerrero-Misas M, Rodríguez-Perálvarez M, De la Mata M. Strategies to improve outcome of patients with hepatocellular carcinoma receiving a liver transplantation. World J Hepatol 2015; 7(4): 649-661 [PMID: 25866602 DOI: 10.4254/wjh.v7.i4.649] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 2.7] [Reference Citation Analysis]
10 Wu C, Liu P, Sun MY, Bian YQ. Macrophage subsets and liver diseases. Shijie Huaren Xiaohua Zazhi 2016; 24(33): 4491-4497 [DOI: 10.11569/wcjd.v24.i33.4491] [Reference Citation Analysis]
11 Wang Q, Chen X, Hay N. Akt as a target for cancer therapy: more is not always better (lessons from studies in mice). Br J Cancer 2017;117:159-63. [PMID: 28557977 DOI: 10.1038/bjc.2017.153] [Cited by in Crossref: 59] [Cited by in F6Publishing: 61] [Article Influence: 11.8] [Reference Citation Analysis]
12 Takeda M, Sakaguchi T, Hiraide T, Shibasaki Y, Morita Y, Kikuchi H, Ikegami K, Setou M, Konno H, Takeuchi H. Role of caveolin-1 in hepatocellular carcinoma arising from non-alcoholic fatty liver disease. Cancer Sci 2018;109:2401-11. [PMID: 29896915 DOI: 10.1111/cas.13659] [Cited by in Crossref: 8] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
13 Postnikov YV, Furusawa T, Haines DC, Factor VM, Bustin M. Loss of the nucleosome-binding protein HMGN1 affects the rate of N-nitrosodiethylamine-induced hepatocarcinogenesis in mice. Mol Cancer Res 2014;12:82-90. [PMID: 24296759 DOI: 10.1158/1541-7786.MCR-13-0392] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
14 De Minicis S, Agostinelli L, Rychlicki C, Sorice GP, Saccomanno S, Candelaresi C, Giaccari A, Trozzi L, Pierantonelli I, Mingarelli E. HCC development is associated to peripheral insulin resistance in a mouse model of NASH. PLoS One. 2014;9:e97136. [PMID: 24853141 DOI: 10.1371/journal.pone.0097136] [Cited by in Crossref: 51] [Cited by in F6Publishing: 50] [Article Influence: 6.4] [Reference Citation Analysis]
15 Vonghia L, Michielsen P, Francque S. Immunological mechanisms in the pathophysiology of non-alcoholic steatohepatitis. Int J Mol Sci. 2013;14:19867-19890. [PMID: 24084730 DOI: 10.3390/ijms141019867] [Cited by in Crossref: 43] [Cited by in F6Publishing: 43] [Article Influence: 4.8] [Reference Citation Analysis]
16 Chen C, Tsukamoto H, Machida K. Oncogenic signaling pathways and origins of tumor-initiating stem-like cells of hepatocellular carcinomas induced by hepatitis C virus, alcohol and/or obesity. Hepatol Int 2014;8:330-8. [DOI: 10.1007/s12072-014-9545-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
17 Li X, Liu C, Ip BC, Hu KQ, Smith DE, Greenberg AS, Wang XD. Tumor progression locus 2 ablation suppressed hepatocellular carcinoma development by inhibiting hepatic inflammation and steatosis in mice. J Exp Clin Cancer Res 2015;34:138. [PMID: 26560698 DOI: 10.1186/s13046-015-0254-2] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
18 Bishayee A. The role of inflammation and liver cancer. Adv Exp Med Biol. 2014;816:401-435. [PMID: 24818732 DOI: 10.1007/978-3-0348-0837-8_16] [Cited by in Crossref: 130] [Cited by in F6Publishing: 123] [Article Influence: 16.3] [Reference Citation Analysis]
19 Orlandi L, Fonseca WF, Enes-marques S, Paffaro VA, Vilela FC, Giusti-paiva A. Sickness behavior is accentuated in rats with metabolic disorders induced by a fructose diet. Journal of Neuroimmunology 2015;289:75-83. [DOI: 10.1016/j.jneuroim.2015.10.014] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
20 Higuera-de-la-Tijera F, Castro-Narro GE, Velarde-Ruiz Velasco JA, Cerda-Reyes E, Moreno-Alcántar R, Aiza-Haddad I, Castillo-Barradas M, Cisneros-Garza LE, Dehesa-Violante M, Flores-Calderón J, González-Huezo MS, Márquez-Guillén E, Muñóz-Espinosa LE, Pérez-Hernández JL, Ramos-Gómez MV, Sierra-Madero J, Sánchez-Ávila JF, Torre-Delgadillo A, Torres R, Marín-López ER, Kershenobich D, Wolpert-Barraza E. Asociación Mexicana de Hepatología A.C. Clinical guideline on hepatitis B. Rev Gastroenterol Mex (Engl Ed) 2021;86:403-32. [PMID: 34483073 DOI: 10.1016/j.rgmxen.2021.04.002] [Reference Citation Analysis]
21 Tamura M, Ito H, Matsui H, Hyodo I. Acetaldehyde is an oxidative stressor for gastric epithelial cells. J Clin Biochem Nutr 2014;55:26-31. [PMID: 25120276 DOI: 10.3164/jcbn.14-12] [Cited by in Crossref: 15] [Cited by in F6Publishing: 8] [Article Influence: 1.9] [Reference Citation Analysis]
22 Castelló B, Aguilera V, Blázquez MT, Rubín Á, García M, Vinaixa C, Benlloch S, Sanjuan F, Montalva E, López R, Berenguer M. Post-transplantation outcome in non-alcoholic steatohepatitis cirrhosis: Comparison with alcoholic cirrhosis. Annals of Hepatology 2019;18:855-61. [DOI: 10.1016/j.aohep.2019.06.014] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
23 Beauchemin N, Arabzadeh A. Carcinoembryonic antigen-related cell adhesion molecules (CEACAMs) in cancer progression and metastasis. Cancer Metastasis Rev 2013;32:643-71. [DOI: 10.1007/s10555-013-9444-6] [Cited by in Crossref: 216] [Cited by in F6Publishing: 218] [Article Influence: 24.0] [Reference Citation Analysis]
24 Setayesh T, Nersesyan A, Mišík M, Ferk F, Langie S, Andrade VM, Haslberger A, Knasmüller S. Impact of obesity and overweight on DNA stability: Few facts and many hypotheses. Mutat Res Rev Mutat Res 2018;777:64-91. [PMID: 30115431 DOI: 10.1016/j.mrrev.2018.07.001] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 7.8] [Reference Citation Analysis]
25 Deng J, Huang Y, Tao R, Fan X, Zhang H, Kong H, Song Q, Huang J. The expression of ETAR in liver cirrhosis and liver cancer. Cancer Biol Ther 2017;18:723-9. [PMID: 28812426 DOI: 10.1080/15384047.2017.1360451] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
26 Rong X, Wei F, Geng Q, Ruan J, Shen H, Li A, Luo R. The Association Between Body Mass Index and the Prognosis and Postoperative Complications of Hepatocellular Carcinoma: A Meta-Analysis. Medicine (Baltimore) 2015;94:e1269. [PMID: 26252292 DOI: 10.1097/MD.0000000000001269] [Cited by in Crossref: 16] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
27 Loaeza-Reyes KJ, Zenteno E, Moreno-Rodríguez A, Torres-Rosas R, Argueta-Figueroa L, Salinas-Marín R, Castillo-Real LM, Pina-Canseco S, Cervera YP. An Overview of Glycosylation and its Impact on Cardiovascular Health and Disease. Front Mol Biosci 2021;8:751637. [PMID: 34869586 DOI: 10.3389/fmolb.2021.751637] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
28 Chen X, Ling Y, Wei Y, Tang J, Ren Y, Zhang B, Jiang F, Li H, Wang R, Wen W, Lv G, Wu M, Chen L, Li L, Wang H. Dual regulation of HMGB1 by combined JNK1/2–ATF2 axis with miR‐200 family in nonalcoholic steatohepatitis in mice. FASEB j 2018;32:2722-34. [DOI: 10.1096/fj.201700875r] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
29 Li CC, Liu C, Fu M, Hu KQ, Aizawa K, Takahashi S, Hiroyuki S, Cheng J, von Lintig J, Wang XD. Tomato Powder Inhibits Hepatic Steatosis and Inflammation Potentially Through Restoring SIRT1 Activity and Adiponectin Function Independent of Carotenoid Cleavage Enzymes in Mice. Mol Nutr Food Res 2018;62:e1700738. [PMID: 29266812 DOI: 10.1002/mnfr.201700738] [Cited by in Crossref: 33] [Cited by in F6Publishing: 24] [Article Influence: 8.3] [Reference Citation Analysis]
30 Zhu Q, Li N, Li F, Zhou Z, Han Q, Lv Y, Sang J, Liu Z. Therapeutic effect of renin angiotensin system inhibitors on liver fibrosis. J Renin Angiotensin Aldosterone Syst. 2016;17:1470320316628717. [PMID: 27009285 DOI: 10.1177/1470320316628717] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.8] [Reference Citation Analysis]
31 D’archivio M, Scazzocchio B, Giovannini C, Masella R. Role of Protocatechuic Acid in Obesity-Related Pathologies. Polyphenols in Human Health and Disease. Elsevier; 2014. pp. 177-89. [DOI: 10.1016/b978-0-12-398456-2.00015-3] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
32 Shimizu Y, Tamura T, Kemmochi A, Owada Y, Ozawa Y, Hisakura K, Matsuzaka T, Shimano H, Nakano N, Sakashita S, Oda T, Ohkohchi N. Oxidative stress and Liver X Receptor agonist induce hepatocellular carcinoma in Non-alcoholic steatohepatitis model. J Gastroenterol Hepatol 2021;36:800-10. [PMID: 32870526 DOI: 10.1111/jgh.15239] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
33 Karin M, Dhar D. Liver carcinogenesis: from naughty chemicals to soothing fat and the surprising role of NRF2. Carcinogenesis. 2016;37:541-546. [PMID: 27207669 DOI: 10.1093/carcin/bgw060] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 5.8] [Reference Citation Analysis]
34 Poland JC, Flynn CR. Bile Acids, Their Receptors, and the Gut Microbiota. Physiology (Bethesda) 2021;36:235-45. [PMID: 34159805 DOI: 10.1152/physiol.00028.2020] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
35 Lee MR, Kim JE, Park JW, Kang MJ, Choi HJ, Bae SJ, Choi YW, Kim KM, Hong JT, Hwang DY. Fermented mulberry (Morus alba) leaves suppress high fat diet-induced hepatic steatosis through amelioration of the inflammatory response and autophagy pathway. BMC Complement Med Ther 2020;20:283. [PMID: 32948162 DOI: 10.1186/s12906-020-03076-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
36 Jeric I, Maurer G, Cavallo AL, Raguz J, Desideri E, Tarkowski B, Parrini M, Fischer I, Zatloukal K, Baccarini M. A cell-autonomous tumour suppressor role of RAF1 in hepatocarcinogenesis. Nat Commun 2016;7:13781. [PMID: 28000790 DOI: 10.1038/ncomms13781] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
37 Lee J. Cyclophilin A as a New Therapeutic Target for Hepatitis C Virus-induced Hepatocellular Carcinoma. Korean J Physiol Pharmacol. 2013;17:375-383. [PMID: 24227937 DOI: 10.4196/kjpp.2013.17.5.375] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
38 Huang M, Wang H, Hu X, Cao X. lncRNA MALAT1 binds chromatin remodeling subunit BRG1 to epigenetically promote inflammation-related hepatocellular carcinoma progression. Oncoimmunology 2019;8:e1518628. [PMID: 30546959 DOI: 10.1080/2162402X.2018.1518628] [Cited by in Crossref: 31] [Cited by in F6Publishing: 22] [Article Influence: 7.8] [Reference Citation Analysis]
39 Griffin JD, Bejarano E, Wang XD, Greenberg AS. Integrated Action of Autophagy and Adipose Tissue Triglyceride Lipase Ameliorates Diet-Induced Hepatic Steatosis in Liver-Specific PLIN2 Knockout Mice. Cells 2021;10:1016. [PMID: 33923083 DOI: 10.3390/cells10051016] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
40 Ren SM, Zhang QZ, Jiang M, Chen ML, Xu XJ, Wang DM, Pan YN, Liu XQ. Systematic characterization of the metabolites of defatted walnut powder extract in vivo and screening of the mechanisms against NAFLD by UPLC-Q-Exactive Orbitrap MS combined with network pharmacology. J Ethnopharmacol 2022;285:114870. [PMID: 34848359 DOI: 10.1016/j.jep.2021.114870] [Reference Citation Analysis]
41 Liu R, Nikolajczyk BS. Tissue Immune Cells Fuel Obesity-Associated Inflammation in Adipose Tissue and Beyond. Front Immunol. 2019;10:1587. [PMID: 31379820 DOI: 10.3389/fimmu.2019.01587] [Cited by in Crossref: 64] [Cited by in F6Publishing: 58] [Article Influence: 21.3] [Reference Citation Analysis]
42 Park SW, Herrema H, Salazar M, Cakir I, Cabi S, Basibuyuk Sahin F, Chiu YH, Cantley LC, Ozcan U. BRD7 regulates XBP1s' activity and glucose homeostasis through its interaction with the regulatory subunits of PI3K. Cell Metab 2014;20:73-84. [PMID: 24836559 DOI: 10.1016/j.cmet.2014.04.006] [Cited by in Crossref: 38] [Cited by in F6Publishing: 40] [Article Influence: 4.8] [Reference Citation Analysis]
43 Zambon Azevedo V, Silaghi CA, Maurel T, Silaghi H, Ratziu V, Pais R. Impact of Sarcopenia on the Severity of the Liver Damage in Patients With Non-alcoholic Fatty Liver Disease. Front Nutr 2022;8:774030. [DOI: 10.3389/fnut.2021.774030] [Reference Citation Analysis]
44 Cabré N, Luciano-Mateo F, Chapski DJ, Baiges-Gaya G, Fernández-Arroyo S, Hernández-Aguilera A, Castañé H, Rodríguez-Tomàs E, París M, Sabench F, Del Castillo D, Del Bas JM, Tomé M, Bodineau C, Sola-García A, López-Miranda J, Martín-Montalvo A, Durán RV, Vondriska TM, Rosa-Garrido M, Camps J, Menéndez JA, Joven J. Glutaminolysis-induced mTORC1 activation drives non-alcoholic steatohepatitis progression. J Hepatol 2021:S0168-8278(21)00302-0. [PMID: 33961941 DOI: 10.1016/j.jhep.2021.04.037] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
45 Dey A, Allen J, Hankey-Giblin PA. Ontogeny and polarization of macrophages in inflammation: blood monocytes versus tissue macrophages. Front Immunol. 2015;5:683. [PMID: 25657646 DOI: 10.3389/fimmu.2014.00683] [Cited by in Crossref: 80] [Cited by in F6Publishing: 97] [Article Influence: 11.4] [Reference Citation Analysis]
46 Mafanda EK, Kandhi R, Bobbala D, Khan MGM, Nandi M, Menendez A, Ramanathan S, Ilangumaran S. Essential role of suppressor of cytokine signaling 1 (SOCS1) in hepatocytes and macrophages in the regulation of liver fibrosis. Cytokine 2019;124:154501. [DOI: 10.1016/j.cyto.2018.07.032] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
47 Zhang G, Cao F, Shi L, Ma T, Zhang L. Contribution of high body mass index and alcohol use to liver cancer-related mortality: A study based on 195 countries or territories. Digestive and Liver Disease 2020;52:221-31. [DOI: 10.1016/j.dld.2019.10.012] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
48 Fuchs CD, Trauner M. Role of bile acids and their receptors in gastrointestinal and hepatic pathophysiology. Nat Rev Gastroenterol Hepatol. [DOI: 10.1038/s41575-021-00566-7] [Reference Citation Analysis]
49 Du J, Cheng X, Shen L, Tan Z, Luo J, Wu X, Liu C, Yang Q, Jiang Y, Tang G, Li X, Zhang S, Zhu L. Methylation of miR-145a-5p promoter mediates adipocytes differentiation. Biochem Biophys Res Commun 2016;475:140-8. [PMID: 27179777 DOI: 10.1016/j.bbrc.2016.05.057] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
50 Matharu Z, Enomoto J, Revzin A. Miniature enzyme-based electrodes for detection of hydrogen peroxide release from alcohol-injured hepatocytes. Anal Chem 2013;85:932-9. [PMID: 23163580 DOI: 10.1021/ac3025619] [Cited by in Crossref: 43] [Cited by in F6Publishing: 36] [Article Influence: 4.3] [Reference Citation Analysis]
51 Wu Y, Tu C, Shao C. Inflammatory indexes in preoperative blood routine to predict early recurrence of hepatocellular carcinoma after curative hepatectomy. BMC Surg 2021;21:178. [PMID: 33794850 DOI: 10.1186/s12893-021-01180-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
52 Ma L, Khatib S, Craig AJ, Wang XW. Toward a Liver Cell Atlas: Understanding Liver Biology in Health and Disease at Single-Cell Resolution. Semin Liver Dis 2021;41:321-30. [PMID: 34130336 DOI: 10.1055/s-0041-1729970] [Reference Citation Analysis]
53 Zhao L, Zhu X, Cong R, Yang X, Zhu Y. The Protective Effects of Danggui-Baizhu-Tang on High-Fat Diet-Induced Obesity in Mice by Activating Thermogenesis. Front Pharmacol 2018;9:1019. [PMID: 30258363 DOI: 10.3389/fphar.2018.01019] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
54 Shteyer E, Villenchik R, Mahamid M, Nator N, Safadi R. Low Serum Lysosomal Acid Lipase Activity Correlates with Advanced Liver Disease. Int J Mol Sci. 2016;17:312. [PMID: 26927097 DOI: 10.3390/ijms17030312] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.2] [Reference Citation Analysis]
55 Baecker A, Liu X, La Vecchia C, Zhang ZF. Worldwide incidence of hepatocellular carcinoma cases attributable to major risk factors. Eur J Cancer Prev. 2018;27:205-212. [PMID: 29489473 DOI: 10.1097/cej.0000000000000428] [Cited by in Crossref: 64] [Cited by in F6Publishing: 41] [Article Influence: 21.3] [Reference Citation Analysis]
56 Wu G. Nutritional Properties of Quinoa. In: Murphy K, Matanguihan J, editors. Quinoa: Improvement and Sustainable Production. Hoboken: John Wiley & Sons, Inc; 2015. pp. 193-210. [DOI: 10.1002/9781118628041.ch11] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 1.4] [Reference Citation Analysis]
57 Çalışkan B, Sinoplu E, İbiş K, Akhan Güzelcan E, Çetin Atalay R, Banoglu E. Synthesis and cellular bioactivities of novel isoxazole derivatives incorporating an arylpiperazine moiety as anticancer agents. J Enzyme Inhib Med Chem 2018;33:1352-61. [PMID: 30251900 DOI: 10.1080/14756366.2018.1504041] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 3.8] [Reference Citation Analysis]
58 Zhou X, Du Y, Xu J, Huang Z, Qiu T, Wang X, Qian J, Zhu W, Liu P. The preoperative lymphocyte to monocyte ratio predicts clinical outcomes in patients with stage II/III gastric cancer. Tumour Biol. 2014;35:11659-11666. [PMID: 25139101 DOI: 10.1007/s13277-014-2504-x] [Cited by in Crossref: 39] [Cited by in F6Publishing: 43] [Article Influence: 4.9] [Reference Citation Analysis]
59 Lee JV, Shah SA, Wellen KE. Obesity, cancer, and acetyl-CoA metabolism. Drug Discov Today Dis Mech 2013;10:e55-61. [PMID: 23878588 DOI: 10.1016/j.ddmec.2013.03.005] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.7] [Reference Citation Analysis]
60 Cao M, George TJ, Prima V, Nelson D, Svetlov S. Argininosuccinate synthase as a novel biomarker for inflammatory conditions. Biomarkers 2013;18:242-9. [PMID: 23510167 DOI: 10.3109/1354750X.2013.773080] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
61 Hasan MT, Campbell E, Sizova O, Lyle V, Akkaraju G, Kirkpatrick DL, Naumov AV. Multi-Drug/Gene NASH Therapy Delivery and Selective Hyperspectral NIR Imaging Using Chirality-Sorted Single-Walled Carbon Nanotubes. Cancers (Basel) 2019;11:E1175. [PMID: 31416250 DOI: 10.3390/cancers11081175] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 4.3] [Reference Citation Analysis]
62 Ip BC, Liu C, Smith DE, Ausman LM, Wang XD. High-refined-carbohydrate and high-fat diets induce comparable hepatic tumorigenesis in male mice. J Nutr 2014;144:647-53. [PMID: 24647392 DOI: 10.3945/jn.113.189613] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
63 Tran NL, Sitia G. New players in non-alcoholic fatty liver disease induced carcinogenesis: lipid dysregulation impairs liver immune surveillance. Hepatobiliary Surg Nutr 2016;5:511-4. [PMID: 28124011 DOI: 10.21037/hbsn.2016.11.08] [Reference Citation Analysis]
64 Barros RK, Cotrim HP, Daltro C, Alves E, de Freitas LA, Daltro C, Oliveira Y. Nonalcoholic steatohepatitis in morbid obese patients: coffee consumption vs. disease severity. Ann Hepatol 2016;15:350-5. [PMID: 27049488 DOI: 10.5604/16652681.1198804] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
65 Da Silva MS, Julien P, Bilodeau JF, Barbier O, Rudkowska I. Trans Fatty Acids Suppress TNF-α-Induced Inflammatory Gene Expression in Endothelial (HUVEC) and Hepatocellular Carcinoma (HepG2) Cells. Lipids 2017;52:315-25. [PMID: 28315997 DOI: 10.1007/s11745-017-4243-4] [Cited by in Crossref: 30] [Cited by in F6Publishing: 25] [Article Influence: 6.0] [Reference Citation Analysis]
66 Ramos-Nino ME. The role of chronic inflammation in obesity-associated cancers. ISRN Oncol. 2013;2013:697521. [PMID: 23819063 DOI: 10.1155/2013/697521] [Cited by in Crossref: 25] [Cited by in F6Publishing: 47] [Article Influence: 2.8] [Reference Citation Analysis]
67 Zhang CH, Sheng JQ, Xie WH, Luo XQ, Xue YN, Xu GL, Chen C. Mechanism and Basis of Traditional Chinese Medicine Against Obesity: Prevention and Treatment Strategies. Front Pharmacol 2021;12:615895. [PMID: 33762940 DOI: 10.3389/fphar.2021.615895] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
68 Yao W, Ba Q, Li X, Li H, Zhang S, Yuan Y, Wang F, Duan X, Li J, Zhang W, Wang H. A Natural CCR2 Antagonist Relieves Tumor-associated Macrophage-mediated Immunosuppression to Produce a Therapeutic Effect for Liver Cancer. EBioMedicine 2017;22:58-67. [PMID: 28754304 DOI: 10.1016/j.ebiom.2017.07.014] [Cited by in Crossref: 43] [Cited by in F6Publishing: 47] [Article Influence: 8.6] [Reference Citation Analysis]
69 Rajesh Y, Sarkar D. Association of Adipose Tissue and Adipokines with Development of Obesity-Induced Liver Cancer. Int J Mol Sci 2021;22:2163. [PMID: 33671547 DOI: 10.3390/ijms22042163] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
70 Wang H, Yang J, Zhang X, Yan L, Yang J. Liver resection in hepatitis B-related hepatocellular carcinoma: clinical outcomes and safety in overweight and obese patients. PLoS One 2014;9:e99281. [PMID: 24914932 DOI: 10.1371/journal.pone.0099281] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
71 Simoni-Nieves A, Salas-Silva S, Chávez-Rodríguez L, Escobedo-Calvario A, Desoteux M, Bucio L, Souza V, Miranda-Labra RU, Muñoz-Espinosa LE, Coulouarn C, Gutiérrez-Ruiz MC, Marquardt JU, Gomez-Quiroz LE. The Consumption of Cholesterol-Enriched Diets Conditions the Development of a Subtype of HCC with High Aggressiveness and Poor Prognosis. Cancers (Basel) 2021;13:1721. [PMID: 33917315 DOI: 10.3390/cancers13071721] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
72 Ramirez-Pedraza M, Fernández M. Interplay Between Macrophages and Angiogenesis: A Double-Edged Sword in Liver Disease. Front Immunol 2019;10:2882. [PMID: 31921146 DOI: 10.3389/fimmu.2019.02882] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
73 Brenner C, Galluzzi L, Kepp O, Kroemer G. Decoding cell death signals in liver inflammation. J Hepatol. 2013;59:583-594. [PMID: 23567086 DOI: 10.1016/j.jhep.2013.03.033] [Cited by in Crossref: 446] [Cited by in F6Publishing: 424] [Article Influence: 49.6] [Reference Citation Analysis]
74 Izquierdo AG, Carreira MC, Amil M, Mosteiro CS, Garcia-Caballero T, Fernandez-Quintela A, Portillo MP, Casanueva FF, Crujeiras AB. An energy restriction-based weight loss intervention is able to reverse the effects of obesity on the expression of liver tumor-promoting genes. FASEB J 2020;34:2312-25. [PMID: 31908001 DOI: 10.1096/fj.201901147RR] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]
75 Giese MA, Hind LE, Huttenlocher A. Neutrophil plasticity in the tumor microenvironment. Blood. 2019;133:2159-2167. [PMID: 30898857 DOI: 10.1182/blood-2018-11-844548] [Cited by in Crossref: 108] [Cited by in F6Publishing: 103] [Article Influence: 36.0] [Reference Citation Analysis]
76 Florio AA, Campbell PT, Zhang X, Zeleniuch-Jacquotte A, Wactawski-Wende J, Smith-Warner SA, Sinha R, Simon TG, Sesso HD, Schairer C, Rosenberg L, Rohan TE, Robien K, Renehan AG, Purdue MP, Poynter JN, Palmer JR, Newton CC, Lu Y, Linet MS, Liao LM, Lee IM, Koshiol J, Kitahara CM, Kirsh VA, Hofmann JN, Graubard BI, Giovannucci E, Gaziano JM, Gapstur SM, Freedman ND, Demuth J, Chong DQ, Chan AT, Buring JE, Bradshaw PT, Beane Freeman LE, McGlynn KA, Petrick JL. Abdominal and gluteofemoral size and risk of liver cancer: The liver cancer pooling project. Int J Cancer 2020;147:675-85. [PMID: 31677159 DOI: 10.1002/ijc.32760] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
77 Mantovani A, Targher G. Type 2 diabetes mellitus and risk of hepatocellular carcinoma: spotlight on nonalcoholic fatty liver disease. Ann Transl Med. 2017;5:270. [PMID: 28758096 DOI: 10.21037/atm.2017.04.41] [Cited by in Crossref: 48] [Cited by in F6Publishing: 49] [Article Influence: 9.6] [Reference Citation Analysis]
78 Kwiecien K, Brzoza P, Bak M, Majewski P, Skulimowska I, Bednarczyk K, Cichy J, Kwitniewski M. The methylation status of the chemerin promoter region located from - 252 to + 258 bp regulates constitutive but not acute-phase cytokine-inducible chemerin expression levels. Sci Rep 2020;10:13702. [PMID: 32792625 DOI: 10.1038/s41598-020-70625-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
79 Kawasaki K, Abe M, Tada F, Tokumoto Y, Chen S, Miyake T, Furukawa S, Matsuura B, Hiasa Y, Onji M. Blockade of B-cell-activating factor signaling enhances hepatic steatosis induced by a high-fat diet and improves insulin sensitivity. Lab Invest 2013;93:311-21. [PMID: 23318884 DOI: 10.1038/labinvest.2012.176] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 2.3] [Reference Citation Analysis]
80 Donath MY, Meier DT, Böni-Schnetzler M. Inflammation in the Pathophysiology and Therapy of Cardiometabolic Disease. Endocr Rev 2019;40:1080-91. [PMID: 31127805 DOI: 10.1210/er.2019-00002] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 12.5] [Reference Citation Analysis]
81 Yan J, Zhao Z, Xia M, Chen S, Wan X, He A, Daniel Sheng G, Wang X, Qian Q, Wang H. Induction of lipid metabolism dysfunction, oxidative stress and inflammation response by tris(1-chloro-2-propyl)phosphate in larval/adult zebrafish. Environ Int 2022;160:107081. [PMID: 35021149 DOI: 10.1016/j.envint.2022.107081] [Reference Citation Analysis]
82 Kwon H, Song K, Han C, Chen W, Wang Y, Dash S, Lim K, Wu T. Inhibition of hedgehog signaling ameliorates hepatic inflammation in mice with nonalcoholic fatty liver disease. Hepatology. 2016;63:1155-1169. [PMID: 26473743 DOI: 10.1002/hep.28289] [Cited by in Crossref: 48] [Cited by in F6Publishing: 47] [Article Influence: 6.9] [Reference Citation Analysis]
83 Li X, Lian F, Liu C, Hu KQ, Wang XD. Isocaloric Pair-Fed High-Carbohydrate Diet Induced More Hepatic Steatosis and Inflammation than High-Fat Diet Mediated by miR-34a/SIRT1 Axis in Mice. Sci Rep 2015;5:16774. [PMID: 26608583 DOI: 10.1038/srep16774] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 4.0] [Reference Citation Analysis]
84 Jager M, Blokzijl F, Sasselli V, Boymans S, Janssen R, Besselink N, Clevers H, van Boxtel R, Cuppen E. Measuring mutation accumulation in single human adult stem cells by whole-genome sequencing of organoid cultures. Nat Protoc 2018;13:59-78. [DOI: 10.1038/nprot.2017.111] [Cited by in Crossref: 21] [Cited by in F6Publishing: 26] [Article Influence: 4.2] [Reference Citation Analysis]
85 Dai X, Ahn KS, Kim C, Siveen KS, Ong TH, Shanmugam MK, Li F, Shi J, Kumar AP, Wang LZ, Goh BC, Magae J, Hui KM, Sethi G. Ascochlorin, an isoprenoid antibiotic inhibits growth and invasion of hepatocellular carcinoma by targeting STAT3 signaling cascade through the induction of PIAS3. Mol Oncol 2015;9:818-33. [PMID: 25624051 DOI: 10.1016/j.molonc.2014.12.008] [Cited by in Crossref: 55] [Cited by in F6Publishing: 54] [Article Influence: 7.9] [Reference Citation Analysis]
86 Brown RB. Potential interaction of inflammatory hyperemia and hyperphosphatemia in tumorigenesis. Future Oncol 2019;15:3909-16. [PMID: 31729262 DOI: 10.2217/fon-2019-0213] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
87 Shalapour S, Karin M. Pas de Deux: Control of Anti-tumor Immunity by Cancer-Associated Inflammation. Immunity. 2019;51:15-26. [PMID: 31315033 DOI: 10.1016/j.immuni.2019.06.021] [Cited by in Crossref: 57] [Cited by in F6Publishing: 51] [Article Influence: 19.0] [Reference Citation Analysis]
88 Zhang W, Zhangyuan G, Wang F, Jin K, Shen H, Zhang L, Yuan X, Wang J, Zhang H, Yu W, Huang R, Xu X, Yin Y, Zhong G, Lin A, Sun B. The zinc finger protein Miz1 suppresses liver tumorigenesis by restricting hepatocyte-driven macrophage activation and inflammation. Immunity 2021;54:1168-1185.e8. [PMID: 34038747 DOI: 10.1016/j.immuni.2021.04.027] [Reference Citation Analysis]
89 Liu Y, Li YQ, Huang SH, Li YL, Xia JW, Jia JS, Wei F, Wang JH, Dai GQ, Wang YC, Li XY, Han LX, Zhang XL, Xiang XD, Zhao WT, Xiao D, Lin XL. Liver-specific over-expression of Cripto-1 in transgenic mice promotes hepatocyte proliferation and deregulated expression of hepatocarcinogenesis-related genes and signaling pathways. Aging (Albany NY) 2021;13:21155-90. [PMID: 34517344 DOI: 10.18632/aging.203402] [Reference Citation Analysis]
90 Bae BK, Park HC, Yoo GS, Choi MS, Oh JH, Yu JI. The Significance of Systemic Inflammation Markers in Intrahepatic Recurrence of Early-Stage Hepatocellular Carcinoma after Curative Treatment. Cancers 2022;14:2081. [DOI: 10.3390/cancers14092081] [Reference Citation Analysis]
91 Shadmani FK, Farzadfar F, Yoosefi M, Mansori K, Shadman RK, Haghdoost A. Premature mortality of gastrointestinal cancer in Iran: trends and projections 2001-2030. BMC Cancer 2020;20:752. [PMID: 32787796 DOI: 10.1186/s12885-020-07132-5] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
92 Aoki T, Yamamoto K. Fundamentals of Physiology and Biology of Vascular System. In: Tanishita K, Yamamoto K, editors. Vascular Engineering. Tokyo: Springer Japan; 2016. pp. 47-68. [DOI: 10.1007/978-4-431-54801-0_3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
93 Zhou F, Sun X. Cholesterol Metabolism: A Double-Edged Sword in Hepatocellular Carcinoma. Front Cell Dev Biol 2021;9:762828. [PMID: 34869352 DOI: 10.3389/fcell.2021.762828] [Reference Citation Analysis]
94 Kim J, Park S, An H, Choi JY, Choi MS, Choi SW, Kim SJ. Differential Tissue-specific and Pathway-specific Anti-obesity Effects of Green Tea and Taeumjowitang, a Traditional Korean Medicine, in Mice. J Cancer Prev 2017;22:147-58. [PMID: 29018779 DOI: 10.15430/JCP.2017.22.3.147] [Reference Citation Analysis]
95 Zheng M, Jiang J, Tang YL, Liang XH. Oncogene and non-oncogene addiction in inflammation-associated cancers. Future Oncol. 2013;9:561-573. [PMID: 23560378 DOI: 10.2217/fon.12.202] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
96 Hawash MM, Kahraman DC, Eren F, Cetin Atalay R, Baytas SN. Synthesis and biological evaluation of novel pyrazolic chalcone derivatives as novel hepatocellular carcinoma therapeutics. Eur J Med Chem 2017;129:12-26. [PMID: 28219046 DOI: 10.1016/j.ejmech.2017.02.002] [Cited by in Crossref: 21] [Cited by in F6Publishing: 15] [Article Influence: 4.2] [Reference Citation Analysis]
97 DeZwaan-McCabe D, Riordan JD, Arensdorf AM, Icardi MS, Dupuy AJ, Rutkowski DT. The stress-regulated transcription factor CHOP promotes hepatic inflammatory gene expression, fibrosis, and oncogenesis. PLoS Genet. 2013;9:e1003937. [PMID: 24367269 DOI: 10.1371/journal.pgen.1003937] [Cited by in Crossref: 47] [Cited by in F6Publishing: 43] [Article Influence: 5.2] [Reference Citation Analysis]
98 Liu Y, She W, Wang F, Li J, Wang J, Jiang W. 3, 3'-Diindolylmethane alleviates steatosis and the progression of NASH partly through shifting the imbalance of Treg/Th17 cells to Treg dominance. Int Immunopharmacol. 2014;23:489-498. [PMID: 25281898 DOI: 10.1016/j.intimp.2014.09.024] [Cited by in Crossref: 35] [Cited by in F6Publishing: 35] [Article Influence: 4.4] [Reference Citation Analysis]
99 Shawon MA, Yousuf MAK, Raheem E, Ahmed S, Dipti TT, Hoque MR, Taniguchi H, Karim MR. Epidemiology, clinical features, and impact of food habits on the risk of hepatocellular carcinoma: A case-control study in Bangladesh. PLoS One 2020;15:e0232121. [PMID: 32339207 DOI: 10.1371/journal.pone.0232121] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
100 Kassel KM, Sullivan BP, Cui W, Copple BL, Luyendyk JP. Therapeutic administration of the direct thrombin inhibitor argatroban reduces hepatic inflammation in mice with established fatty liver disease. Am J Pathol. 2012;181:1287-1295. [PMID: 22841818 DOI: 10.1016/j.ajpath.2012.06.011] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 2.8] [Reference Citation Analysis]
101 Yokoyama-Mashima S, Yogosawa S, Kanegae Y, Hirooka S, Yoshida S, Horiuchi T, Ohashi T, Yanaga K, Saruta M, Oikawa T, Yoshida K. Forced expression of DYRK2 exerts anti-tumor effects via apoptotic induction in liver cancer. Cancer Lett 2019;451:100-9. [PMID: 30851422 DOI: 10.1016/j.canlet.2019.02.046] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
102 Imai K, Takai K, Hanai T, Shiraki M, Suzuki Y, Hayashi H, Naiki T, Nishigaki Y, Tomita E, Shimizu M, Moriwaki H. Impact of serum chemerin levels on liver functional reserves and platelet counts in patients with hepatocellular carcinoma. Int J Mol Sci 2014;15:11294-306. [PMID: 24968270 DOI: 10.3390/ijms150711294] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis]
103 Tian Y, Wong VW, Chan HL, Cheng AS. Epigenetic regulation of hepatocellular carcinoma in non-alcoholic fatty liver disease. Semin Cancer Biol. 2013;23:471-482. [PMID: 24018165 DOI: 10.1016/j.semcancer.2013.08.010] [Cited by in Crossref: 51] [Cited by in F6Publishing: 48] [Article Influence: 5.7] [Reference Citation Analysis]
104 Gonzalez LL, Garrie K, Turner MD. Type 2 diabetes - An autoinflammatory disease driven by metabolic stress. Biochim Biophys Acta Mol Basis Dis. 2018;1864:3805-3823. [PMID: 30251697 DOI: 10.1016/j.bbadis.2018.08.034] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 7.0] [Reference Citation Analysis]
105 Hawash M, Kahraman DC, Cetin-Atalay R, Baytas SN. Induction of Apoptosis in Hepatocellular Carcinoma Cell Lines by Novel Indolylacrylamide Derivatives: Synthesis and Biological Evaluation. Chem Biodivers 2021;18:e2001037. [PMID: 33713038 DOI: 10.1002/cbdv.202001037] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
106 Zhong X, Zeng M, Bian H, Zhong C, Xiao F. An evaluation of the protective role of vitamin C in reactive oxygen species-induced hepatotoxicity due to hexavalent chromium in vitro and in vivo. J Occup Med Toxicol 2017;12:15. [PMID: 28638434 DOI: 10.1186/s12995-017-0161-x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 3.8] [Reference Citation Analysis]
107 Heinrich S, Castven D, Galle PR, Marquardt JU. Translational Considerations to Improve Response and Overcome Therapy Resistance in Immunotherapy for Hepatocellular Carcinoma. Cancers (Basel) 2020;12:E2495. [PMID: 32899197 DOI: 10.3390/cancers12092495] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
108 Sahuri-Arisoylu M, Brody LP, Parkinson JR, Parkes H, Navaratnam N, Miller AD, Thomas EL, Frost G, Bell JD. Reprogramming of hepatic fat accumulation and 'browning' of adipose tissue by the short-chain fatty acid acetate. Int J Obes (Lond). 2016;40:955-963. [PMID: 26975441 DOI: 10.1038/ijo.2016.23] [Cited by in Crossref: 89] [Cited by in F6Publishing: 79] [Article Influence: 14.8] [Reference Citation Analysis]
109 Chen WD, Yu D, Forman BM, Huang W, Wang YD. Deficiency of G-protein-coupled bile acid receptor Gpbar1 (TGR5) enhances chemically induced liver carcinogenesis. Hepatology 2013;57:656-66. [PMID: 22911633 DOI: 10.1002/hep.26019] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 2.3] [Reference Citation Analysis]
110 Kaufmann B, Reca A, Kim AD, Feldstein AE. Novel Mechanisms for Resolution of Liver Inflammation: Therapeutic Implications. Semin Liver Dis 2021;41:150-62. [PMID: 34107544 DOI: 10.1055/s-0041-1723031] [Reference Citation Analysis]
111 Vonghia L, Ruyssers N, Schrijvers D, Pelckmans P, Michielsen P, De Clerck L, Ramon A, Jirillo E, Ebo D, De Winter B, Bridts C, Francque S. CD4+ROR γ t++ and Tregs in a Mouse Model of Diet-Induced Nonalcoholic Steatohepatitis. Mediators Inflamm 2015;2015:239623. [PMID: 26229237 DOI: 10.1155/2015/239623] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 2.1] [Reference Citation Analysis]
112 Suresh D, Srinivas AN, Kumar DP. Etiology of Hepatocellular Carcinoma: Special Focus on Fatty Liver Disease. Front Oncol 2020;10:601710. [PMID: 33330100 DOI: 10.3389/fonc.2020.601710] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
113 Narasimamurthy R, Hatori M, Nayak SK, Liu F, Panda S, Verma IM. Circadian clock protein cryptochrome regulates the expression of proinflammatory cytokines. Proc Natl Acad Sci U S A 2012;109:12662-7. [PMID: 22778400 DOI: 10.1073/pnas.1209965109] [Cited by in Crossref: 227] [Cited by in F6Publishing: 216] [Article Influence: 22.7] [Reference Citation Analysis]
114 Jois T, Sleeman MW. The regulation and role of carbohydrate response element-binding protein in metabolic homeostasis and disease. J Neuroendocrinol 2017;29:e12473. [DOI: 10.1111/jne.12473] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
115 Chakarov S, Blériot C, Ginhoux F. Role of adipose tissue macrophages in obesity-related disorders. J Exp Med 2022;219:e20211948. [PMID: 35543703 DOI: 10.1084/jem.20211948] [Reference Citation Analysis]
116 Bakiri L, Wagner EF. Mouse models for liver cancer. Mol Oncol 2013;7:206-23. [PMID: 23428636 DOI: 10.1016/j.molonc.2013.01.005] [Cited by in Crossref: 107] [Cited by in F6Publishing: 98] [Article Influence: 11.9] [Reference Citation Analysis]
117 Kim S, Choi S, Dutta M, Asubonteng JO, Polunas M, Goedken M, Gonzalez FJ, Cui JY, Gyamfi MA. Pregnane X receptor exacerbates nonalcoholic fatty liver disease accompanied by obesity- and inflammation-prone gut microbiome signature. Biochem Pharmacol 2021;:114698. [PMID: 34303710 DOI: 10.1016/j.bcp.2021.114698] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
118 Yang WY, Rao PS, Luo YC, Lin HK, Huang SH, Yang JM, Yuh CH. Omics-based Investigation of Diet-induced Obesity Synergized with HBx, Src, and p53 Mutation Accelerating Hepatocarcinogenesis in Zebrafish Model. Cancers (Basel) 2019;11:E1899. [PMID: 31795276 DOI: 10.3390/cancers11121899] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
119 Mohan CD, Bharathkumar H, Bulusu KC, Pandey V, Rangappa S, Fuchs JE, Shanmugam MK, Dai X, Li F, Deivasigamani A. Development of a novel azaspirane that targets the Janus kinase-signal transducer and activator of transcription (STAT) pathway in hepatocellular carcinoma in vitro and in vivo. J Biol Chem. 2014;289:34296-34307. [PMID: 25320076 DOI: 10.1074/jbc.m114.601104] [Cited by in Crossref: 97] [Cited by in F6Publishing: 43] [Article Influence: 12.1] [Reference Citation Analysis]
120 Malik AI, Rowan-Carroll A, Williams A, Lemieux CL, Long AS, Arlt VM, Phillips DH, White PA, Yauk CL. Hepatic genotoxicity and toxicogenomic responses in Muta™Mouse males treated with dibenz[a,h]anthracene. Mutagenesis 2013;28:543-54. [PMID: 23793610 DOI: 10.1093/mutage/get031] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
121 Aleksandrova K, Boeing H, Nöthlings U, Jenab M, Fedirko V, Kaaks R, Lukanova A, Trichopoulou A, Trichopoulos D, Boffetta P. Inflammatory and metabolic biomarkers and risk of liver and biliary tract cancer. Hepatology. 2014;60:858-871. [PMID: 24443059 DOI: 10.1002/hep.27016] [Cited by in Crossref: 112] [Cited by in F6Publishing: 115] [Article Influence: 14.0] [Reference Citation Analysis]
122 Yeh MM, Brunt EM. Pathological Features of Fatty Liver Disease. Gastroenterology 2014;147:754-64. [DOI: 10.1053/j.gastro.2014.07.056] [Cited by in Crossref: 184] [Cited by in F6Publishing: 162] [Article Influence: 23.0] [Reference Citation Analysis]
123 Ambade A, Satishchandran A, Saha B, Gyongyosi B, Lowe P, Kodys K, Catalano D, Szabo G. Hepatocellular carcinoma is accelerated by NASH involving M2 macrophage polarization mediated by hif-1αinduced IL-10. Oncoimmunology 2016;5:e1221557. [PMID: 27853646 DOI: 10.1080/2162402X.2016.1221557] [Cited by in Crossref: 35] [Cited by in F6Publishing: 29] [Article Influence: 5.8] [Reference Citation Analysis]
124 Luo Y, Lin H. Inflammation initiates a vicious cycle between obesity and nonalcoholic fatty liver disease. Immun Inflamm Dis 2021;9:59-73. [PMID: 33332766 DOI: 10.1002/iid3.391] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
125 Coia H, Ma N, Hou Y, Permaul E, Berry DL, Cruz MI, Pannkuk E, Girgis M, Zhu Z, Lee Y, Rodriquez O, Cheema A, Chung FL. Theaphenon E prevents fatty liver disease and increases CD4+ T cell survival in mice fed a high-fat diet. Clin Nutr 2021;40:110-9. [PMID: 32439267 DOI: 10.1016/j.clnu.2020.04.033] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
126 Jiang L, Jiang S, Lin Y, Yang H, Zhao Z, Xie Z, Lin Y, Long H. Combination of body mass index and oxidized low density lipoprotein receptor 1 in prognosis prediction of patients with squamous non-small cell lung cancer. Oncotarget 2015;6:22072-80. [PMID: 26061746 DOI: 10.18632/oncotarget.4299] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 2.5] [Reference Citation Analysis]
127 Zhou M, Yang H, Learned RM, Tian H, Ling L. Non-cell-autonomous activation of IL-6/STAT3 signaling mediates FGF19-driven hepatocarcinogenesis. Nat Commun 2017;8:15433. [PMID: 28508871 DOI: 10.1038/ncomms15433] [Cited by in Crossref: 69] [Cited by in F6Publishing: 68] [Article Influence: 13.8] [Reference Citation Analysis]
128 Kerry R, Goovaerts P, Ingram B, Tereault C. Spatial Analysis of Lung Cancer Mortality in the American West to Improve Allocation of Medical Resources. Appl Spatial Analysis 2020;13:823-50. [DOI: 10.1007/s12061-019-09331-5] [Cited by in Crossref: 3] [Article Influence: 1.0] [Reference Citation Analysis]
129 Matsunaga Y, Nakatsu Y, Fukushima T, Okubo H, Iwashita M, Sakoda H, Fujishiro M, Yamamotoya T, Kushiyama A, Takahashi S. LUBAC Formation Is Impaired in the Livers of Mice with MCD-Dependent Nonalcoholic Steatohepatitis. Mediators Inflamm. 2015;2015:125380. [PMID: 26170532 DOI: 10.1155/2015/125380] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 2.1] [Reference Citation Analysis]
130 Yan R, Chu J, Zhou Y, Shan W, Hu Y, Lin M, Zhao Y, Sun R, Wang Z, Lv L, Wang L, Yao J, Zhang N. Ubiquitin-specific protease 22 ameliorates chronic alcohol-associated liver disease by regulating BRD4. Pharmacol Res 2021;168:105594. [PMID: 33826947 DOI: 10.1016/j.phrs.2021.105594] [Reference Citation Analysis]
131 Dong K, Zhang Y, Huang JJ, Xia SS, Yang Y. Shorter leucocyte telomere length as a potential biomarker for nonalcoholic fatty liver disease-related advanced fibrosis in T2DM patients. Ann Transl Med 2020;8:308. [PMID: 32355752 DOI: 10.21037/atm.2020.03.10] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
132 Gao Y, Yuan CY, Yuan W. Will targeting PI3K/Akt/mTOR signaling work in hematopoietic malignancies? Stem Cell Investig 2016;3:31. [PMID: 27583254 DOI: 10.21037/sci.2016.07.02] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
133 Nath LR, Gorantla JN, Thulasidasan AK, Vijayakurup V, Shah S, Anwer S, Joseph SM, Antony J, Veena KS, Sundaram S, Marelli UK, Lankalapalli RS, Anto RJ. Evaluation of uttroside B, a saponin from Solanum nigrum Linn, as a promising chemotherapeutic agent against hepatocellular carcinoma. Sci Rep 2016;6:36318. [PMID: 27808117 DOI: 10.1038/srep36318] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 2.2] [Reference Citation Analysis]
134 Healy ME, Lahiri S, Hargett SR, Chow JD, Byrne FL, Breen DS, Kenwood BM, Taddeo EP, Lackner C, Caldwell SH, Hoehn KL. Dietary sugar intake increases liver tumor incidence in female mice. Sci Rep 2016;6:22292. [PMID: 26924712 DOI: 10.1038/srep22292] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.8] [Reference Citation Analysis]
135 Taniai M, Hashimoto E, Tobari M, Kodama K, Tokushige K, Yamamoto M, Takayama T, Sugitani M, Sano K, Kondo F, Fukusato T. Clinicopathological investigation of steatohepatitic hepatocellular carcinoma: A multicenter study using immunohistochemical analysis of adenoma-related markers. Hepatol Res. 2018;48:947-955. [PMID: 30058778 DOI: 10.1111/hepr.13203] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
136 Coia H, Ma N, He AR, Kallakury B, Berry DL, Permaul E, Makambi KH, Fu Y, Chung FL. Detection of a lipid peroxidation-induced DNA adduct across liver disease stages. Hepatobiliary Surg Nutr 2018;7:85-97. [PMID: 29744335 DOI: 10.21037/hbsn.2017.06.01] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
137 Huang KW, Jayant K, Lee PH, Yang PC, Hsiao CY, Habib N, Sodergren MH. Positive Immuno-Modulation Following Radiofrequency Assisted Liver Resection in Hepatocellular Carcinoma. J Clin Med 2019;8:E385. [PMID: 30893948 DOI: 10.3390/jcm8030385] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
138 Anstee QM, Reeves HL, Kotsiliti E, Govaere O, Heikenwalder M. From NASH to HCC: current concepts and future challenges. Nat Rev Gastroenterol Hepatol. 2019;16:411-428. [PMID: 31028350 DOI: 10.1038/s41575-019-0145-7] [Cited by in Crossref: 268] [Cited by in F6Publishing: 286] [Article Influence: 89.3] [Reference Citation Analysis]
139 Cook DJ, Patra B, Kuttippurathu L, Hoek JB, Vadigepalli R. A novel, dynamic pattern-based analysis of NF-κB binding during the priming phase of liver regeneration reveals switch-like functional regulation of target genes. Front Physiol 2015;6:189. [PMID: 26217230 DOI: 10.3389/fphys.2015.00189] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
140 Zimmermann E, Gamborg M, Holst C, Baker JL, Sørensen TI, Berentzen TL. Body mass index in school-aged children and the risk of routinely diagnosed non-alcoholic fatty liver disease in adulthood: a prospective study based on the Copenhagen School Health Records Register. BMJ Open 2015;5:e006998. [PMID: 25941179 DOI: 10.1136/bmjopen-2014-006998] [Cited by in Crossref: 174] [Cited by in F6Publishing: 25] [Article Influence: 24.9] [Reference Citation Analysis]
141 Schulte L, Scheiner B, Voigtländer T, Koch S, Schweitzer N, Marhenke S, Ivanyi P, Manns MP, Rodt T, Hinrichs JB, Weinmann A, Pinter M, Vogel A, Kirstein MM. Treatment with metformin is associated with a prolonged survival in patients with hepatocellular carcinoma. Liver Int 2019;39:714-26. [PMID: 30663219 DOI: 10.1111/liv.14048] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 7.7] [Reference Citation Analysis]
142 Donath MY, Dinarello CA, Mandrup-Poulsen T. Targeting innate immune mediators in type 1 and type 2 diabetes. Nat Rev Immunol 2019;19:734-46. [PMID: 31501536 DOI: 10.1038/s41577-019-0213-9] [Cited by in Crossref: 87] [Cited by in F6Publishing: 71] [Article Influence: 29.0] [Reference Citation Analysis]
143 Kompella P, Vasquez KM. Obesity and cancer: A mechanistic overview of metabolic changes in obesity that impact genetic instability. Mol Carcinog 2019;58:1531-50. [PMID: 31168912 DOI: 10.1002/mc.23048] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 3.7] [Reference Citation Analysis]
144 Bai L, Liu Z, Fang Q, Yan Q, Shi O, Bao P, Mu L, Chen X, Zhang T. The trends and projections in the incidence and mortality of liver cancer in urban Shanghai: a population-based study from 1973 to 2020. Clin Epidemiol 2018;10:277-88. [PMID: 29563840 DOI: 10.2147/CLEP.S153951] [Cited by in Crossref: 14] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
145 Komori T, Tanaka M, Furuta H, Akamizu T, Miyajima A, Morikawa Y. Oncostatin M is a potential agent for the treatment of obesity and related metabolic disorders: a study in mice. Diabetologia 2015;58:1868-76. [DOI: 10.1007/s00125-015-3613-9] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.4] [Reference Citation Analysis]
146 Nderitu P, Bosco C, Garmo H, Holmberg L, Malmström H, Hammar N, Walldius G, Jungner I, Ross P, Van Hemelrijck M. The association between individual metabolic syndrome components, primary liver cancer and cirrhosis: A study in the Swedish AMORIS cohort. Int J Cancer 2017;141:1148-60. [PMID: 28577304 DOI: 10.1002/ijc.30818] [Cited by in Crossref: 29] [Cited by in F6Publishing: 23] [Article Influence: 5.8] [Reference Citation Analysis]
147 Suceveanu A, Mazilu L, Voinea F, Suceveanu A, Parepa IR, Catrinoiu D, Tuta L. Obesity, an independent risk factor for hepatocellular carcinoma (HCC) in NAFLD non-cirrhotic patients. ARS Medica Tomitana 2013;19:51-6. [DOI: 10.2478/arsm-2013-0009] [Reference Citation Analysis]
148 Kim J, Kwon EY, Park S, Kim JR, Choi SW, Choi MS, Kim SJ. Integrative systems analysis of diet-induced obesity identified a critical transition in the transcriptomes of the murine liver and epididymal white adipose tissue. Int J Obes (Lond) 2016;40:338-45. [PMID: 26268884 DOI: 10.1038/ijo.2015.147] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
149 Eggert T, Greten TF. Tumor regulation of the tissue environment in the liver. Pharmacol Ther 2017;173:47-57. [PMID: 28167218 DOI: 10.1016/j.pharmthera.2017.02.005] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 5.8] [Reference Citation Analysis]
150 Ip BC, Hu KQ, Liu C, Smith DE, Obin MS, Ausman LM, Wang XD. Lycopene metabolite, apo-10'-lycopenoic acid, inhibits diethylnitrosamine-initiated, high fat diet-promoted hepatic inflammation and tumorigenesis in mice. Cancer Prev Res (Phila). 2013;6:1304-1316. [PMID: 24085778 DOI: 10.1158/1940-6207.capr-13-0178] [Cited by in Crossref: 59] [Cited by in F6Publishing: 37] [Article Influence: 6.6] [Reference Citation Analysis]
151 İbiş K, Nalbat E, Çalışkan B, Kahraman DC, Cetin-Atalay R, Banoglu E. Synthesis and biological evaluation of novel isoxazole-piperazine hybrids as potential anti-cancer agents with inhibitory effect on liver cancer stem cells. Eur J Med Chem 2021;221:113489. [PMID: 33951549 DOI: 10.1016/j.ejmech.2021.113489] [Reference Citation Analysis]
152 Zhou X, Xu L, Huang Z, Zhang L, Zhang H, Zhu W, Liu P. The hematologic markers as prognostic factors in patients with resectable gastric cancer. Cancer Biomark 2016;17:359-67. [PMID: 27434296 DOI: 10.3233/CBM-160648] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 3.2] [Reference Citation Analysis]
153 Amer J, Salhab A, Noureddin M, Doron S, Abu-Tair L, Ghantous R, Mahamid M, Safadi R. Insulin signaling as a potential natural killer cell checkpoint in fatty liver disease. Hepatol Commun 2018;2:285-98. [PMID: 29507903 DOI: 10.1002/hep4.1146] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
154 Sahini N, Borlak J. Recent insights into the molecular pathophysiology of lipid droplet formation in hepatocytes. Prog Lipid Res. 2014;54:86-112. [PMID: 24607340 DOI: 10.1016/j.plipres.2014.02.002] [Cited by in Crossref: 63] [Cited by in F6Publishing: 59] [Article Influence: 7.9] [Reference Citation Analysis]
155 Galuppo R, Ramaiah D, Ponte OM, Gedaly R. Molecular therapies in hepatocellular carcinoma: what can we target? Dig Dis Sci. 2014;59:1688-1697. [PMID: 24573715 DOI: 10.1007/s10620-014-3058-x] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 3.4] [Reference Citation Analysis]
156 Ezhilarasan D. Critical role of estrogen in the progression of chronic liver diseases. Hepatobiliary & Pancreatic Diseases International 2020;19:429-34. [DOI: 10.1016/j.hbpd.2020.03.011] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
157 Carroll HK, Duffy AG, O'Farrelly C. Liver Immunology, Immunotherapy, and Liver Cancers: Time for a Rethink? Semin Liver Dis 2022. [PMID: 35263795 DOI: 10.1055/s-0042-1744143] [Reference Citation Analysis]
158 Yu Y, Li H, Zhang B, Pan X, Zhu X, Ding Y, Li G. Peptide network for detection of tissue-remodeling enzyme in the prognosis of hepatocellular carcinoma. ACS Appl Mater Interfaces 2015;7:4401-5. [PMID: 25629926 DOI: 10.1021/am5089378] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
159 Rios-Colon L, Arthur E, Niture S, Qi Q, Moore JT, Kumar D. The Role of Exosomes in the Crosstalk between Adipocytes and Liver Cancer Cells. Cells 2020;9:E1988. [PMID: 32872417 DOI: 10.3390/cells9091988] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
160 Hassan W, Ding L, Gao RY, Liu J, Shang J. Interleukin-6 signal transduction and its role in hepatic lipid metabolic disorders. Cytokine 2014;66:133-42. [PMID: 24491813 DOI: 10.1016/j.cyto.2013.12.017] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 3.8] [Reference Citation Analysis]
161 Zacchini F, Heber MF, Arena R, Radczuk N, Jankowska U, Ptak GE. Perturbations of the hepatic proteome behind the onset of metabolic disorders in mouse offspring developed following embryo manipulation. Theriogenology 2021;171:119-29. [PMID: 34052779 DOI: 10.1016/j.theriogenology.2021.05.022] [Reference Citation Analysis]
162 Ray I, Dasgupta A, De RK. Succinate aggravates NAFLD progression to liver cancer on the onset of obesity: An in silico model. J Bioinform Comput Biol 2018;16:1850008. [PMID: 29954288 DOI: 10.1142/S0219720018500087] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
163 Ip BC, Wang XD. Non-alcoholic steatohepatitis and hepatocellular carcinoma: implications for lycopene intervention. Nutrients. 2014;6:124-162. [PMID: 24379011 DOI: 10.3390/nu6010124] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 3.6] [Reference Citation Analysis]
164 Baffy G. Hepatocellular Carcinoma in Non-alcoholic Fatty Liver Disease: Epidemiology, Pathogenesis, and Prevention. J Clin Transl Hepatol 2013;1:131-7. [PMID: 26355775 DOI: 10.14218/JCTH.2013.00005] [Cited by in Crossref: 7] [Cited by in F6Publishing: 23] [Article Influence: 0.8] [Reference Citation Analysis]
165 Gao Y, Gao J, Li M, Zheng Y, Wang Y, Zhang H, Wang W, Chu Y, Wang X, Xu M, Cheng T, Ju Z, Yuan W. Rheb1 promotes tumor progression through mTORC1 in MLL-AF9-initiated murine acute myeloid leukemia. J Hematol Oncol 2016;9:36. [PMID: 27071307 DOI: 10.1186/s13045-016-0264-3] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
166 Kolb R, Zhang W. Obesity and Breast Cancer: A Case of Inflamed Adipose Tissue. Cancers (Basel) 2020;12:E1686. [PMID: 32630445 DOI: 10.3390/cancers12061686] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
167 Fucho R, Casals N, Serra D, Herrero L. Ceramides and mitochondrial fatty acid oxidation in obesity. FASEB J 2017;31:1263-72. [PMID: 28003342 DOI: 10.1096/fj.201601156R] [Cited by in Crossref: 49] [Cited by in F6Publishing: 29] [Article Influence: 8.2] [Reference Citation Analysis]
168 Niemeyer DJ, Simo KA, Iannitti DA, McKillop IH. Ablation therapy for hepatocellular carcinoma: past, present and future perspectives. Hepat Oncol 2014;1:67-79. [PMID: 30190942 DOI: 10.2217/hep.13.8] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
169 Ma C, Kesarwala AH, Eggert T, Medina-Echeverz J, Kleiner DE, Jin P, Stroncek DF, Terabe M, Kapoor V, ElGindi M. NAFLD causes selective CD4(+) T lymphocyte loss and promotes hepatocarcinogenesis. Nature. 2016;531:253-257. [PMID: 26934227 DOI: 10.1038/nature16969] [Cited by in Crossref: 281] [Cited by in F6Publishing: 279] [Article Influence: 46.8] [Reference Citation Analysis]
170 Liu H, Li H, Jin L, Li G, Hu S, Ning C, Guo J, Shuai S, Li X, Li M. Long Noncoding RNA GAS5 Suppresses 3T3-L1 Cells Adipogenesis Through miR-21a-5p/PTEN Signal Pathway. DNA Cell Biol 2018;37:767-77. [PMID: 30020817 DOI: 10.1089/dna.2018.4264] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 4.8] [Reference Citation Analysis]
171 Pais R, Fartoux L, Goumard C, Scatton O, Wendum D, Rosmorduc O, Ratziu V. Temporal trends, clinical patterns and outcomes of NAFLD-related HCC in patients undergoing liver resection over a 20-year period. Aliment Pharmacol Ther 2017;46:856-63. [PMID: 28857208 DOI: 10.1111/apt.14261] [Cited by in Crossref: 43] [Cited by in F6Publishing: 46] [Article Influence: 8.6] [Reference Citation Analysis]
172 Merola N, Castillo J, Benavente-García O, Ros G, Nieto G. The Effect of Consumption of Citrus Fruit and Olive Leaf Extract on Lipid Metabolism. Nutrients 2017;9:E1062. [PMID: 28954421 DOI: 10.3390/nu9101062] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 2.2] [Reference Citation Analysis]
173 Yuan JM, Grouls M, Carmella SG, Wang R, Heskin A, Jiang Y, Tan YT, Adams-Haduch J, Gao YT, Hecht SS. Prediagnostic levels of urinary 8-epi-prostaglandin F2α and prostaglandin E2 metabolite, biomarkers of oxidative damage and inflammation, and risk of hepatocellular carcinoma. Carcinogenesis 2019;40:989-97. [PMID: 30615102 DOI: 10.1093/carcin/bgy180] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
174 Aslan M, Afşar E, Kırımlıoglu E, Çeker T, Yılmaz Ç. Antiproliferative Effects of Thymoquinone in MCF-7 Breast and HepG2 Liver Cancer Cells: Possible Role of Ceramide and ER Stress. Nutr Cancer 2021;73:460-72. [PMID: 32286088 DOI: 10.1080/01635581.2020.1751216] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
175 Song SH, Kwon C, Jin SM, Park HJ, Chung CW, Kwon SW, Ko KH, Hong SP. Clinical characteristics of acute cholecystitis with elevated liver enzymes not associated with choledocholithiasis. European Journal of Gastroenterology & Hepatology 2014;26:452-7. [DOI: 10.1097/meg.0000000000000053] [Cited by in Crossref: 21] [Cited by in F6Publishing: 6] [Article Influence: 2.6] [Reference Citation Analysis]
176 Fan L, Xu H, Li D, Li H, Lu D. A novel long noncoding RNA, AC092834.1, regulates the adipogenic differentiation of human adipose-derived mesenchymal stem cells via the DKK1/Wnt/β-catenin signaling pathway. Biochem Biophys Res Commun 2020;525:747-54. [PMID: 32145912 DOI: 10.1016/j.bbrc.2020.02.140] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
177 Miethe C, Zamora M, Torres L, Raign KG, Groll CJ, Price RS. Characterizing the differential physiological effects of adipocytokines visfatin and resistin in liver cancer cells. Horm Mol Biol Clin Investig 2019;38:/j/hmbci. [PMID: 30917102 DOI: 10.1515/hmbci-2018-0068] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
178 de Cleva R, Duarte LF, Crenitte MRF, de Oliveira CPM, Pajecki D, Santo MA. Use of noninvasive markers to predict advanced fibrosis/cirrhosis in severe obesity. Surgery for Obesity and Related Diseases 2016;12:862-7. [DOI: 10.1016/j.soard.2015.11.011] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
179 Abdelkhalek NK, Risha E, El-Adl MA, Salama MF, Dawood MAO. Antibacterial and antioxidant activity of clove oil against Streptococcus iniae infection in Nile tilapia (Oreochromis niloticus) and its effect on hepatic hepcidin expression. Fish Shellfish Immunol 2020;104:478-88. [PMID: 32470509 DOI: 10.1016/j.fsi.2020.05.064] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
180 Zhang Y, Zhao J, Zhou SF, Yu ZL, Wang XY, Zhu PL, Chu ZS, Pan SY, Xie M, Ko KM. Biochemical mechanism underlying hypertriglyceridemia and hepatic steatosis/hepatomegaly induced by acute schisandrin B treatment in mice. Lipids Health Dis 2017;16:8. [PMID: 28086886 DOI: 10.1186/s12944-017-0406-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
181 Johnson PJ. How Do Mechanisms of Hepatocarcinogenesis (HBV, HCV, and NASH) Affect Our Understanding and Approach to HCC? American Society of Clinical Oncology Educational Book 2013. [DOI: 10.14694/edbook_am.2013.33.e132] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
182 Liu Y, Wang Z, Cao Y, Zhang G, Chen W, Jiang C. Preoperative inflammation-based markers predict early and late recurrence of hepatocellular carcinoma after curative hepatectomy. Hepatobiliary & Pancreatic Diseases International 2016;15:266-74. [DOI: 10.1016/s1499-3872(16)60094-2] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
183 Yang WS, Zeng XF, Liu ZN, Zhao QH, Tan YT, Gao J, Li HL, Xiang YB. Diet and liver cancer risk: a narrative review of epidemiological evidence. Br J Nutr 2020;124:330-40. [PMID: 32234090 DOI: 10.1017/S0007114520001208] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
184 Wu D, Dawson NA, Levings MK. Obesity-Associated Adipose Tissue Inflammation and Transplantation. Am J Transplant 2016;16:743-50. [PMID: 26755439 DOI: 10.1111/ajt.13578] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 2.7] [Reference Citation Analysis]
185 Lv S, Qiu X, Li J, Liang J, Li W, Zhang C, Zhang Z, Luan B. Glucagon-induced extracellular cAMP regulates hepatic lipid metabolism. Journal of Endocrinology 2017;234:73-87. [DOI: 10.1530/joe-16-0649] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
186 Yang Y, Guo Y, Tan S, Ke B, Tao J, Liu H, Jiang J, Chen J, Chen G, Wu B. β-Arrestin1 enhances hepatocellular carcinogenesis through inflammation-mediated Akt signalling. Nat Commun 2015;6:7369. [PMID: 26077142 DOI: 10.1038/ncomms8369] [Cited by in Crossref: 39] [Cited by in F6Publishing: 40] [Article Influence: 5.6] [Reference Citation Analysis]
187 Li S, Hong M, Tan HY, Wang N, Feng Y. Insights into the Role and Interdependence of Oxidative Stress and Inflammation in Liver Diseases. Oxid Med Cell Longev 2016;2016:4234061. [PMID: 28070230 DOI: 10.1155/2016/4234061] [Cited by in Crossref: 98] [Cited by in F6Publishing: 99] [Article Influence: 16.3] [Reference Citation Analysis]
188 Rohm TV, Meier DT, Olefsky JM, Donath MY. Inflammation in obesity, diabetes, and related disorders. Immunity 2022;55:31-55. [PMID: 35021057 DOI: 10.1016/j.immuni.2021.12.013] [Reference Citation Analysis]
189 Tamura M, Matsui H, Kaneko T, Hyodo I. Alcohol is an oxidative stressor for gastric epithelial cells: detection of superoxide in living cells. J Clin Biochem Nutr 2013;53:75-80. [PMID: 24062603 DOI: 10.3164/jcbn.13-32] [Cited by in Crossref: 36] [Cited by in F6Publishing: 30] [Article Influence: 4.0] [Reference Citation Analysis]
190 Lérias JR, Paraschoudi G, de Sousa E, Martins J, Condeço C, Figueiredo N, Carvalho C, Dodoo E, Castillo-Martin M, Beltrán A, Ligeiro D, Rao M, Zumla A, Maeurer M. Microbes as Master Immunomodulators: Immunopathology, Cancer and Personalized Immunotherapies. Front Cell Dev Biol 2019;7:362. [PMID: 32039196 DOI: 10.3389/fcell.2019.00362] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
191 Kim KE, Ko KH, Heo RW, Yi CO, Shin HJ, Kim JY, Park JH, Nam S, Kim H, Roh GS. Artemisia annua Leaf Extract Attenuates Hepatic Steatosis and Inflammation in High-Fat Diet-Fed Mice. J Med Food. 2016;19:290-299. [PMID: 26741655 DOI: 10.1089/jmf.2015.3527] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 3.2] [Reference Citation Analysis]
192 Zhang Y, Ren J. Introduction. Clinical and Experimental Pharmacology and Physiology 2012;39:158-60. [DOI: 10.1111/j.1440-1681.2012.05671.x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
193 Mao H, Feng XZ, Guang SH. Treating liver cancer with antibiotics? Acta Pharmacol Sin 2013;34:989-90. [PMID: 23912552 DOI: 10.1038/aps.2013.102] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
194 Masum M, Howard JT, Grigsby TJ. Combined alcohol use and weight status effects on mortality risk among adults: Analysis of the National Health Interview Survey linked mortality files, 2001-2015. Drug Alcohol Depend 2022;230:109206. [PMID: 34890926 DOI: 10.1016/j.drugalcdep.2021.109206] [Reference Citation Analysis]
195 Zhu Y, Zhang JY, Wei YL, Hao JY, Lei YQ, Zhao WB, Xiao YH, Sun AD. The polyphenol-rich extract from chokeberry (Aronia melanocarpa L.) modulates gut microbiota and improves lipid metabolism in diet-induced obese rats. Nutr Metab (Lond) 2020;17:54. [PMID: 32655675 DOI: 10.1186/s12986-020-00473-9] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
196 Zhou H, Urso CJ, Jadeja V. Saturated Fatty Acids in Obesity-Associated Inflammation. J Inflamm Res 2020;13:1-14. [PMID: 32021375 DOI: 10.2147/JIR.S229691] [Cited by in Crossref: 25] [Cited by in F6Publishing: 18] [Article Influence: 12.5] [Reference Citation Analysis]
197 Horvatova A, Utaipan T, Otto AC, Zhang Y, Gan-Schreier H, Pavek P, Pathil A, Stremmel W, Chamulitrat W. Ursodeoxycholyl lysophosphatidylethanolamide negatively regulates TLR-mediated lipopolysaccharide response in human THP-1-derived macrophages. Eur J Pharmacol 2018;825:63-74. [PMID: 29475064 DOI: 10.1016/j.ejphar.2018.02.030] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
198 Jiang X, Liang L, Chen G, Liu C. Modulation of Immune Components on Stem Cell and Dormancy in Cancer. Cells 2021;10:2826. [PMID: 34831048 DOI: 10.3390/cells10112826] [Reference Citation Analysis]
199 Wu Q, Chen JX, Chen Y, Cai LL, Wang XZ, Guo WH, Zheng JF. The chemokine receptor CCR10 promotes inflammation-driven hepatocarcinogenesis via PI3K/Akt pathway activation. Cell Death Dis 2018;9:232. [PMID: 29445190 DOI: 10.1038/s41419-018-0267-9] [Cited by in Crossref: 8] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
200 Streba LA, Vere CC, Rogoveanu I, Streba CT. Nonalcoholic fatty liver disease, metabolic risk factors, and hepatocellular carcinoma: an open question. World J Gastroenterol 2015;21:4103-10. [PMID: 25892859 DOI: 10.3748/wjg.v21.i14.4103] [Cited by in CrossRef: 94] [Cited by in F6Publishing: 84] [Article Influence: 13.4] [Reference Citation Analysis]
201 Ajayi EIO, Molehin OR, Oloyede OI, Kumar V, Amara VR, Kaur J, Karpe P, Tikoo K. Liver mitochondrial membrane permeability modulation in insulin-resistant, uninephrectomised male rats by Clerodendrum volubile P. Beauv and Manihot esculenta Crantz. Clin Phytosci 2019;5. [DOI: 10.1186/s40816-019-0124-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
202 Sun B, Li J, Shao D, Pan Y, Chen Y, Li S, Yao X, Li H, Liu W, Zhang M, Zhang X, Chen L. Adipose tissue-secreted miR-27a promotes liver cancer by targeting FOXO1 in obese individuals. Onco Targets Ther 2015;8:735-44. [PMID: 25897249 DOI: 10.2147/OTT.S80945] [Cited by in Crossref: 26] [Cited by in F6Publishing: 16] [Article Influence: 3.7] [Reference Citation Analysis]
203 Liu H, Li Y, Wei Q, Liu C, Bolund L, Vajta G, Dou H, Yang W, Xu Y, Luan J, Wang J, Yang H, Staunstrup NH, Du Y. Development of transgenic minipigs with expression of antimorphic human cryptochrome 1. PLoS One 2013;8:e76098. [PMID: 24146819 DOI: 10.1371/journal.pone.0076098] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
204 Bluemel S, Wang Y, Lee S, Schnabl B. Tumor necrosis factor alpha receptor 1 deficiency in hepatocytes does not protect from non-alcoholic steatohepatitis, but attenuates insulin resistance in mice. World J Gastroenterol 2020; 26(33): 4933-4944 [PMID: 32952340 DOI: 10.3748/wjg.v26.i33.4933] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
205 Wunderlich CM, Hövelmeyer N, Wunderlich FT. Mechanisms of chronic JAK-STAT3-SOCS3 signaling in obesity. JAKSTAT 2013;2:e23878. [PMID: 24058813 DOI: 10.4161/jkst.23878] [Cited by in Crossref: 51] [Cited by in F6Publishing: 75] [Article Influence: 6.4] [Reference Citation Analysis]
206 Rawla P, Sunkara T, Muralidharan P, Raj JP. Update in global trends and aetiology of hepatocellular carcinoma. Contemp Oncol (Pozn). 2018;22:141-150. [PMID: 30455585 DOI: 10.5114/wo.2018.78941] [Cited by in Crossref: 63] [Cited by in F6Publishing: 71] [Article Influence: 15.8] [Reference Citation Analysis]
207 Nakagawa H, Fujiwara N, Tateishi R, Arano T, Nakagomi R, Kondo M, Minami T, Sato M, Uchino K, Enooku K, Asaoka Y, Kondo Y, Shiina S, Yoshida H, Koike K. Impact of serum levels of interleukin-6 and adiponectin on all-cause, liver-related, and liver-unrelated mortality in chronic hepatitis C patients. J Gastroenterol Hepatol 2015;30:379-88. [PMID: 25168107 DOI: 10.1111/jgh.12719] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
208 Toriguchi K, Hatano E, Tanabe K, Takemoto K, Nakamura K, Koyama Y, Seo S, Taura K, Uemoto S. Attenuation of steatohepatitis, fibrosis, and carcinogenesis in mice fed a methionine-choline deficient diet by CCAAT/enhancer-binding protein homologous protein deficiency. J Gastroenterol Hepatol. 2014;29:1109-1118. [PMID: 24329600 DOI: 10.1111/jgh.12481] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 3.5] [Reference Citation Analysis]
209 Toita R, Kawano T, Fujita S, Murata M, Kang JH. Increased hepatic inflammation in a normal-weight mouse after long-term high-fat diet feeding. J Toxicol Pathol 2018;31:43-7. [PMID: 29479139 DOI: 10.1293/tox.2017-0038] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
210 Said A, Ghufran A. Epidemic of non-alcoholic fatty liver disease and hepatocellular carcinoma. World J Clin Oncol 2017; 8(6): 429-436 [PMID: 29291167 DOI: 10.5306/wjco.v8.i6.429] [Cited by in CrossRef: 52] [Cited by in F6Publishing: 48] [Article Influence: 10.4] [Reference Citation Analysis]
211 Lu H, Ye C, Feng X, Liu J, Bhaumik M, Xia B, Liu C, Shen Z. Spontaneous Development of Hepatocellular Carcinoma and B-Cell Lymphoma in Mosaic and Heterozygous Brca2 and Cdkn1a Interacting Protein Knockout Mice. Am J Pathol 2020;190:1175-87. [PMID: 32201259 DOI: 10.1016/j.ajpath.2020.01.020] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
212 Baig MS, Zaichick SV, Mao M, de Abreu AL, Bakhshi FR, Hart PC, Saqib U, Deng J, Chatterjee S, Block ML, Vogel SM, Malik AB, Consolaro ME, Christman JW, Minshall RD, Gantner BN, Bonini MG. NOS1-derived nitric oxide promotes NF-κB transcriptional activity through inhibition of suppressor of cytokine signaling-1. J Exp Med 2015;212:1725-38. [PMID: 26324446 DOI: 10.1084/jem.20140654] [Cited by in Crossref: 60] [Cited by in F6Publishing: 60] [Article Influence: 8.6] [Reference Citation Analysis]
213 Fekry B, Ribas-Latre A, Baumgartner C, Deans JR, Kwok C, Patel P, Fu L, Berdeaux R, Sun K, Kolonin MG, Wang SH, Yoo SH, Sladek FM, Eckel-Mahan K. Incompatibility of the circadian protein BMAL1 and HNF4α in hepatocellular carcinoma. Nat Commun 2018;9:4349. [PMID: 30341289 DOI: 10.1038/s41467-018-06648-6] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 7.8] [Reference Citation Analysis]
214 Schwartz L, Peres S, Jolicoeur M, da Veiga Moreira J. Cancer and Alzheimer's disease: intracellular pH scales the metabolic disorders. Biogerontology 2020;21:683-94. [PMID: 32617766 DOI: 10.1007/s10522-020-09888-6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
215 Badely M, Sepandi M, Samadi M, Parastouei K, Taghdir M. The effect of whey protein on the components of metabolic syndrome in overweight and obese individuals; a systematic review and meta-analysis. Diabetes Metab Syndr 2019;13:3121-31. [PMID: 31790966 DOI: 10.1016/j.dsx.2019.11.001] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
216 Terakura D, Shimizu M, Iwasa J, Baba A, Kochi T, Ohno T, Kubota M, Shirakami Y, Shiraki M, Takai K, Tsurumi H, Tanaka T, Moriwaki H. Preventive effects of branched-chain amino acid supplementation on the spontaneous development of hepatic preneoplastic lesions in C57BL/KsJ-db/db obese mice. Carcinogenesis 2012;33:2499-506. [PMID: 23027617 DOI: 10.1093/carcin/bgs303] [Cited by in Crossref: 38] [Cited by in F6Publishing: 37] [Article Influence: 3.8] [Reference Citation Analysis]
217 Berentzen TL, Gamborg M, Holst C, Sørensen TI, Baker JL. Body mass index in childhood and adult risk of primary liver cancer. J Hepatol. 2014;60:325-330. [PMID: 24076363 DOI: 10.1016/j.jhep.2013.09.015] [Cited by in Crossref: 72] [Cited by in F6Publishing: 65] [Article Influence: 8.0] [Reference Citation Analysis]
218 Mazmishvili K, Jayant K, Janikashvili N, Kikodze N, Mizandari M, Pantsulaia I, Paksashvili N, Sodergren MH, Reccia I, Pai M, Habib N, Chikovani T. Study to evaluate the immunomodulatory effects of radiofrequency ablation compared to surgical resection for liver cancer. J Cancer 2018;9:3187-95. [PMID: 30210642 DOI: 10.7150/jca.25084] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
219 Katsanos AH, Kyriakidi K, Karassa FB, Politis D, Skamnelos A, Christodoulou DK, Katsanos KH. Biomarker Development in Chronic Inflammatory Diseases. In: D'hooghe T, editor. Biomarkers for Endometriosis. Cham: Springer International Publishing; 2017. pp. 41-75. [DOI: 10.1007/978-3-319-59856-7_3] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
220 McGreal SR, Rumi K, Soares MJ, Woolbright BL, Jaeschke H, Apte U. Disruption of Estrogen Receptor Alpha in Rats Results in Faster Initiation of Compensatory Regeneration Despite Higher Liver Injury After Carbon Tetrachloride Treatment. Int J Toxicol 2017;36:199-206. [PMID: 28481132 DOI: 10.1177/1091581817706067] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
221 Buj R, Aird KM. Deoxyribonucleotide Triphosphate Metabolism in Cancer and Metabolic Disease. Front Endocrinol (Lausanne) 2018;9:177. [PMID: 29720963 DOI: 10.3389/fendo.2018.00177] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 7.3] [Reference Citation Analysis]
222 Higuera-de-la-Tijera F, Castro-Narro GE, Velarde-Ruiz Velasco JA, Cerda-Reyes E, Moreno-Alcántar R, Aiza-Haddad I, Castillo-Barradas M, Cisneros-Garza LE, Dehesa-Violante M, Flores-Calderón J, González-Huezo MS, Márquez-Guillén E, Muñóz-Espinosa LE, Pérez-Hernández JL, Ramos-Gómez MV, Sierra-Madero J, Sánchez-Ávila JF, Torre-Delgadillo A, Torres R, Marín-López ER, Kershenobich D, Wolpert-Barraza E. Asociación Mexicana de Hepatología A.C. Clinical guideline on hepatitis B. Rev Gastroenterol Mex 2021:S0375-0906(21)00061-6. [PMID: 34384668 DOI: 10.1016/j.rgmx.2021.04.002] [Reference Citation Analysis]
223 Wang ZC, Liu LZ, Liu XY, Hu JJ, Wu YN, Shi JY, Yang LX, Duan M, Wang XY, Zhou J. Genetic polymorphisms of the multidrug resistance 1 gene MDR1 and the risk of hepatocellular carcinoma. Tumour Biol. 2015;36:7007-7015. [PMID: 25861753 DOI: 10.1007/s13277-015-3407-1] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
224 Cho JA, Park E. Curcumin utilizes the anti-inflammatory response pathway to protect the intestine against bacterial invasion. Nutr Res Pract 2015;9:117-22. [PMID: 25861416 DOI: 10.4162/nrp.2015.9.2.117] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 3.1] [Reference Citation Analysis]
225 Jiang C, Iwaisako K, Cong M, Diggle K, Hassanein T, Brenner DA, Kisseleva T. Traditional Chinese Medicine Fuzheng Huayu Prevents Development of Liver Fibrosis in Mice. Arch Clin Biomed Res 2020;4:561-80. [PMID: 33210080 DOI: 10.26502/acbr.50170125] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
226 Qiao Z, Wang X, Zhang H, Han J, Feng H, Wu Z. Single-Cell Transcriptomics Reveals That Metabolites Produced by Paenibacillus bovis sp. nov. BD3526 Ameliorate Type 2 Diabetes in GK Rats by Downregulating the Inflammatory Response. Front Microbiol 2020;11:568805. [PMID: 33424779 DOI: 10.3389/fmicb.2020.568805] [Reference Citation Analysis]
227 Liu R, Wei Y, Zeng Q, Chan K, Xiao X, Zhao X, Chen M, Ouyang F, Chen D, Zheng L, Lao X, Kuang D. Chemokine (C-X-C motif) receptor 3-positive B cells link interleukin-17 inflammation to protumorigenic macrophage polarization in human hepatocellular carcinoma: HEPATOBILIARY MALIGNANCIES. Hepatology 2015;62:1779-90. [DOI: 10.1002/hep.28020] [Cited by in Crossref: 44] [Cited by in F6Publishing: 44] [Article Influence: 6.3] [Reference Citation Analysis]
228 Jung H, Wee J, Kim K, Sung H, Shin H. Effect of onion (Allium cepa) ultra-high pressure processing and hot water extracts on the serum cholesterol level in high cholesterol-fed rats. Food Sci Biotechnol 2015;24:287-94. [DOI: 10.1007/s10068-015-0038-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
229 Wang M, Han J, Xing H, Zhang H, Li Z, Liang L, Li C, Dai S, Wu M, Shen F, Yang T. Dysregulated fatty acid metabolism in hepatocellular carcinoma. Hepat Oncol 2016;3:241-51. [PMID: 30191046 DOI: 10.2217/hep-2016-0012] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 4.8] [Reference Citation Analysis]
230 Njei B, McCarty TR, Sharma P, Lange A, Najafian N, Ngu JN, Ngomba VE, Echouffo-Tcheugui JB. Bariatric Surgery and Hepatocellular Carcinoma: a Propensity Score-Matched Analysis. Obes Surg 2018;28:3880-9. [PMID: 30069863 DOI: 10.1007/s11695-018-3431-5] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
231 Ehlken H, Krishna-Subramanian S, Ochoa-Callejero L, Kondylis V, Nadi NE, Straub BK, Schirmacher P, Walczak H, Kollias G, Pasparakis M. Death receptor-independent FADD signalling triggers hepatitis and hepatocellular carcinoma in mice with liver parenchymal cell-specific NEMO knockout. Cell Death Differ 2014;21:1721-32. [PMID: 24971483 DOI: 10.1038/cdd.2014.83] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 2.9] [Reference Citation Analysis]
232 Gérard C, Gonze D, Lemaigre F, Novák B. A model for the epigenetic switch linking inflammation to cell transformation: deterministic and stochastic approaches. PLoS Comput Biol. 2014;10:e1003455. [PMID: 24499937 DOI: 10.1371/journal.pcbi.1003455] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
233 Martínez-Galán JP, Ontibón-Echeverri CM, Campos Costa M, Batista-Duharte A, Guerso Batista V, Mesa V, Monti R, Veloso de Paula A, Martins Baviera A. Enzymatic synthesis of capric acid-rich structured lipids and their effects on mice with high-fat diet-induced obesity. Food Res Int 2021;148:110602. [PMID: 34507747 DOI: 10.1016/j.foodres.2021.110602] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
234 Marcelo KL, Lin F, Rajapakshe K, Dean A, Gonzales N, Coarfa C, Means AR, Goldie LC, York B. Deciphering hepatocellular responses to metabolic and oncogenic stress. J Biol Methods 2015;2:e28. [PMID: 26504887 DOI: 10.14440/jbm.2015.77] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
235 Herquel B, Ouararhni K, Martianov I, Le Gras S, Ye T, Keime C, Lerouge T, Jost B, Cammas F, Losson R, Davidson I. Trim24-repressed VL30 retrotransposons regulate gene expression by producing noncoding RNA. Nat Struct Mol Biol 2013;20:339-46. [PMID: 23377542 DOI: 10.1038/nsmb.2496] [Cited by in Crossref: 50] [Cited by in F6Publishing: 49] [Article Influence: 5.6] [Reference Citation Analysis]
236 Neelgundmath M, Dinesh KR, Mohan CD, Li F, Dai X, Siveen KS, Paricharak S, Mason DJ, Fuchs JE, Sethi G, Bender A, Rangappa KS, Kotresh O, Basappa. Novel synthetic coumarins that targets NF-κB in Hepatocellular carcinoma. Bioorganic & Medicinal Chemistry Letters 2015;25:893-7. [DOI: 10.1016/j.bmcl.2014.12.065] [Cited by in Crossref: 45] [Cited by in F6Publishing: 40] [Article Influence: 6.4] [Reference Citation Analysis]
237 Elisia I, Lam V, Cho B, Hay M, Li MY, Kapeluto J, Elliott T, Harris D, Bu L, Jia W, Leung H, Mohn W, Krystal G. Exploratory examination of inflammation state, immune response and blood cell composition in a human obese cohort to identify potential markers predicting cancer risk. PLoS One 2020;15:e0228633. [PMID: 32027700 DOI: 10.1371/journal.pone.0228633] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 5.5] [Reference Citation Analysis]
238 Wong YH, Wu CC, Lin CL, Chen TS, Chang TH, Chen BS. Applying NGS Data to Find Evolutionary Network Biomarkers from the Early and Late Stages of Hepatocellular Carcinoma. Biomed Res Int 2015;2015:391475. [PMID: 26366411 DOI: 10.1155/2015/391475] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
239 Narci K, Kahraman DC, Koyas A, Ersahin T, Tuncbag N, Atalay RC. Context dependent isoform specific PI3K inhibition confers drug resistance in hepatocellular carcinoma cells. BMC Cancer 2022;22:320. [PMID: 35331184 DOI: 10.1186/s12885-022-09357-y] [Reference Citation Analysis]
240 Zhang W, Wang X, Jiang R, Hou J, Mu X, Li G, Sun B. Effect of Tumor Size on Cancer-Specific Survival in Small Hepatocellular Carcinoma. Mayo Clin Proc 2015;90:1187-95. [PMID: 26231292 DOI: 10.1016/j.mayocp.2015.06.018] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
241 Lu Y, Chang N, Zhao X, Xue R, Liu J, Yang L, Li L. Activated Neutrophils Secrete Chitinase-Like 1 and Attenuate Liver Inflammation by Inhibiting Pro-Inflammatory Macrophage Responses. Front Immunol 2022;13:824385. [DOI: 10.3389/fimmu.2022.824385] [Reference Citation Analysis]
242 Jayant K, Habib N, Huang KW, Podda M, Warwick J, Arasaradnam R. Immunological Basis of Genesis of Hepatocellular Carcinoma: Unique Challenges and Potential Opportunities through Immunomodulation. Vaccines (Basel) 2020;8:E247. [PMID: 32456200 DOI: 10.3390/vaccines8020247] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
243 Liu Y, Qi X, Zeng Z, Wang L, Wang J, Zhang T, Xu Q, Shen C, Zhou G, Yang S, Chen X, Lu F. CRISPR/Cas9-mediated p53 and Pten dual mutation accelerates hepatocarcinogenesis in adult hepatitis B virus transgenic mice. Sci Rep 2017;7:2796. [PMID: 28584302 DOI: 10.1038/s41598-017-03070-8] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 5.0] [Reference Citation Analysis]
244 Hernández-Alvarez MI, Sebastián D, Vives S, Ivanova S, Bartoccioni P, Kakimoto P, Plana N, Veiga SR, Hernández V, Vasconcelos N, Peddinti G, Adrover A, Jové M, Pamplona R, Gordaliza-Alaguero I, Calvo E, Cabré N, Castro R, Kuzmanic A, Boutant M, Sala D, Hyotylainen T, Orešič M, Fort J, Errasti-Murugarren E, Rodrígues CMP, Orozco M, Joven J, Cantó C, Palacin M, Fernández-Veledo S, Vendrell J, Zorzano A. Deficient Endoplasmic Reticulum-Mitochondrial Phosphatidylserine Transfer Causes Liver Disease. Cell 2019;177:881-895.e17. [PMID: 31051106 DOI: 10.1016/j.cell.2019.04.010] [Cited by in Crossref: 82] [Cited by in F6Publishing: 78] [Article Influence: 41.0] [Reference Citation Analysis]
245 Li J, Wu T, Zhang X, Du Y, Wei B, Wang J. Clinical Application of Liver Diseases Diagnosis using Ultrahigh-sensitive Liquid Chromatography-Mass Spectrometry for Sialic Acids Detection. Journal of Chromatography A 2022. [DOI: 10.1016/j.chroma.2022.462837] [Reference Citation Analysis]
246 Liang S, Ma HY, Zhong Z, Dhar D, Liu X, Xu J, Koyama Y, Nishio T, Karin D, Karin G, Mccubbin R, Zhang C, Hu R, Yang G, Chen L, Ganguly S, Lan T, Karin M, Kisseleva T, Brenner DA. NADPH Oxidase 1 in Liver Macrophages Promotes Inflammation and Tumor Development in Mice. Gastroenterology 2019;156:1156-1172.e6. [PMID: 30445007 DOI: 10.1053/j.gastro.2018.11.019] [Cited by in Crossref: 33] [Cited by in F6Publishing: 37] [Article Influence: 8.3] [Reference Citation Analysis]
247 Kim Y, Ejaz A, Tayal A, Spolverato G, Bridges JF, Anders RA, Pawlik TM. Temporal trends in population-based death rates associated with chronic liver disease and liver cancer in the United States over the last 30 years. Cancer 2014;120:3058-65. [PMID: 24917245 DOI: 10.1002/cncr.28843] [Cited by in Crossref: 40] [Cited by in F6Publishing: 38] [Article Influence: 5.0] [Reference Citation Analysis]
248 He H, Wu Z, Li S, Chen K, Wang D, Zou H, Chen H, Li Y, Liu Z, Qu C. TRAF7 enhances ubiquitin-degradation of KLF4 to promote hepatocellular carcinoma progression. Cancer Lett 2020;469:380-9. [PMID: 31730901 DOI: 10.1016/j.canlet.2019.11.012] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
249 Jordy AB, Kraakman MJ, Gardner T, Estevez E, Kammoun HL, Weir JM, Kiens B, Meikle PJ, Febbraio MA, Henstridge DC. Analysis of the liver lipidome reveals insights into the protective effect of exercise on high-fat diet-induced hepatosteatosis in mice. Am J Physiol Endocrinol Metab 2015;308:E778-91. [PMID: 25714675 DOI: 10.1152/ajpendo.00547.2014] [Cited by in Crossref: 34] [Cited by in F6Publishing: 32] [Article Influence: 4.9] [Reference Citation Analysis]
250 Ding J, Wang H. Multiple interactive factors in hepatocarcinogenesis. Cancer Lett. 2014;346:17-23. [PMID: 24374016 DOI: 10.1016/j.canlet.2013.12.024] [Cited by in Crossref: 63] [Cited by in F6Publishing: 60] [Article Influence: 7.0] [Reference Citation Analysis]
251 Rozenblum N, Zeira E, Scaiewicz V, Bulvik B, Gourevitch S, Yotvat H, Galun E, Goldberg SN. Oncogenesis: An "Off-Target" Effect of Radiofrequency Ablation. Radiology 2015;276:426-32. [PMID: 26203709 DOI: 10.1148/radiol.2015141695] [Cited by in Crossref: 51] [Cited by in F6Publishing: 48] [Article Influence: 7.3] [Reference Citation Analysis]
252 Chen Y, Varghese Z, Ruan XZ. The molecular pathogenic role of inflammatory stress in dysregulation of lipid homeostasis and hepatic steatosis. Genes Dis 2014;1:106-12. [PMID: 30258859 DOI: 10.1016/j.gendis.2014.07.007] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 2.4] [Reference Citation Analysis]
253 Merath K, Mehta R, Hyer JM, Bagante F, Sahara K, Alexandrescu S, Marques HP, Aldrighetti L, Maithel SK, Pulitano C, Weiss MJ, Bauer TW, Shen F, Poultsides GA, Soubrane O, Martel G, Koerkamp BG, Guglielmi A, Itaru E, Ejaz A, Pawlik TM. Impact of body mass index on tumor recurrence among patients undergoing curative-intent resection of intrahepatic cholangiocarcinoma- a multi-institutional international analysis. Eur J Surg Oncol 2019;45:1084-91. [PMID: 30871884 DOI: 10.1016/j.ejso.2019.03.004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
254 Wu SE, Charles HW, Park JS, Goldenberg AS, Deipolyi AR. Obesity conveys poor outcome in patients with hepatocellular carcinoma treated by transarterial chemoembolization. Diagn Interv Imaging 2017;98:37-42. [PMID: 27372418 DOI: 10.1016/j.diii.2016.06.002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
255 Liu S, Xu X, Fang Z, Ning Y, Deng B, Pan X, He Y, Yang Z, Huang K, Li J. Piezo1 impairs hepatocellular tumor growth via deregulation of the MAPK-mediated YAP signaling pathway. Cell Calcium 2021;95:102367. [PMID: 33610907 DOI: 10.1016/j.ceca.2021.102367] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
256 Rodríguez-Calvo R, Moreno-Vedia J, Girona J, Ibarretxe D, Martínez-Micaelo N, Merino J, Plana N, Masana L. Relationship Between Fatty Acid Binding Protein 4 and Liver Fat in Individuals at Increased Cardiometabolic Risk. Front Physiol 2021;12:781789. [PMID: 34966292 DOI: 10.3389/fphys.2021.781789] [Reference Citation Analysis]
257 Tessitore A, Mastroiaco V, Vetuschi A, Sferra R, Pompili S, Cicciarelli G, Barnabei R, Capece D, Zazzeroni F, Capalbo C, Alesse E. Development of hepatocellular cancer induced by long term low fat-high carbohydrate diet in a NAFLD/NASH mouse model. Oncotarget 2017;8:53482-94. [PMID: 28881825 DOI: 10.18632/oncotarget.18585] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
258 Singh MK, Das BK, Choudhary S, Gupta D, Patil UK. Diabetes and hepatocellular carcinoma: A pathophysiological link and pharmacological management. Biomed Pharmacother 2018;106:991-1002. [PMID: 30119271 DOI: 10.1016/j.biopha.2018.06.095] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
259 Meng Z, Liu L, Yan S, Sun W, Jia M, Tian S, Huang S, Zhou Z, Zhu W. Gut Microbiota: A Key Factor in the Host Health Effects Induced by Pesticide Exposure? J Agric Food Chem 2020;68:10517-31. [PMID: 32902962 DOI: 10.1021/acs.jafc.0c04678] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
260 Meng Z, Wang D, Liu W, Li R, Yan S, Jia M, Zhang L, Zhou Z, Zhu W. Perinatal exposure to Bisphenol S (BPS) promotes obesity development by interfering with lipid and glucose metabolism in male mouse offspring. Environ Res 2019;173:189-98. [PMID: 30921577 DOI: 10.1016/j.envres.2019.03.038] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 6.3] [Reference Citation Analysis]
261 Zou Y, Chen Z, Lou Q, Han H, Zhang Y, Chen Z, Ma Z, Shi N, Jin H. A Novel Blood Index-Based Model to Predict Hepatitis B Virus-Associated Hepatocellular Carcinoma Recurrence After Curative Hepatectomy: Guidance on Adjuvant Transcatheter Arterial Chemoembolization Choice. Front Oncol 2021;11:755235. [PMID: 35004275 DOI: 10.3389/fonc.2021.755235] [Reference Citation Analysis]
262 Vongsuvanh R, George J, Qiao L, van der Poorten D. Visceral adiposity in gastrointestinal and hepatic carcinogenesis. Cancer Lett. 2013;330:1-10. [PMID: 23201597 DOI: 10.1016/j.canlet.2012.11.038] [Cited by in Crossref: 46] [Cited by in F6Publishing: 44] [Article Influence: 4.6] [Reference Citation Analysis]
263 Yoshimoto S, Loo TM, Atarashi K, Kanda H, Sato S, Oyadomari S, Iwakura Y, Oshima K, Morita H, Hattori M, Honda K, Ishikawa Y, Hara E, Ohtani N. Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome. Nature. 2013;499:97-101. [PMID: 23803760 DOI: 10.1038/nature12347] [Cited by in Crossref: 1104] [Cited by in F6Publishing: 1009] [Article Influence: 122.7] [Reference Citation Analysis]
264 Michelotti A, de Scordilli M, Palmero L, Guardascione M, Masala M, Roncato R, Foltran L, Ongaro E, Puglisi F. NAFLD-Related Hepatocarcinoma: The Malignant Side of Metabolic Syndrome. Cells 2021;10:2034. [PMID: 34440803 DOI: 10.3390/cells10082034] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
265 Sakurai Y, Kubota N, Yamauchi T, Kadowaki T. Role of Insulin Resistance in MAFLD. Int J Mol Sci 2021;22:4156. [PMID: 33923817 DOI: 10.3390/ijms22084156] [Reference Citation Analysis]
266 Farrell G. Insulin Resistance, Obesity, and Liver Cancer. Clinical Gastroenterology and Hepatology 2014;12:117-9. [DOI: 10.1016/j.cgh.2013.07.040] [Cited by in Crossref: 30] [Cited by in F6Publishing: 24] [Article Influence: 3.8] [Reference Citation Analysis]
267 Calvente CJ, Tameda M, Johnson CD, Del Pilar H, Lin YC, Adronikou N, De Mollerat Du Jeu X, Llorente C, Boyer J, Feldstein AE. Neutrophils contribute to spontaneous resolution of liver inflammation and fibrosis via microRNA-223. J Clin Invest 2019;129:4091-109. [PMID: 31295147 DOI: 10.1172/JCI122258] [Cited by in Crossref: 49] [Cited by in F6Publishing: 27] [Article Influence: 16.3] [Reference Citation Analysis]
268 Zhao LY, Yang DD, Ma XK, Liu MM, Wu DH, Zhang XP, Ruan DY, Lin JX, Wen JY, Chen J, Lin Q, Dong M, Qi JJ, Hu PS, Zeng ZL, Chen ZH, Wu XY. The Prognostic Value of aspartate aminotransferase to lymphocyte ratio and systemic immune-inflammation index for Overall Survival of Hepatocellular Carcinoma Patients Treated with palliative Treatments. J Cancer 2019;10:2299-311. [PMID: 31258733 DOI: 10.7150/jca.30663] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
269 Jayant K, Habib N, Huang KW, Warwick J, Arasaradnam R. Recent Advances: The Imbalance of Immune Cells and Cytokines in the Pathogenesis of Hepatocellular Carcinoma. Diagnostics (Basel). 2020;10. [PMID: 32466214 DOI: 10.3390/diagnostics10050338] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
270 Ceylan H. Identification of hub genes associated with obesity-induced hepatocellular carcinoma risk based on integrated bioinformatics analysis. Med Oncol 2021;38:63. [PMID: 33900477 DOI: 10.1007/s12032-021-01510-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
271 Ilan Y. Compounds of the sphingomyelin-ceramide-glycosphingolipid pathways as secondary messenger molecules: new targets for novel therapies for fatty liver disease and insulin resistance. Am J Physiol Gastrointest Liver Physiol 2016;310:G1102-17. [PMID: 27173510 DOI: 10.1152/ajpgi.00095.2016] [Cited by in Crossref: 36] [Cited by in F6Publishing: 35] [Article Influence: 6.0] [Reference Citation Analysis]
272 Sakai H, Shirakami Y, Shimizu M. Chemoprevention of obesity-related liver carcinogenesis by using pharmaceutical and nutraceutical agents. World J Gastroenterol 2016; 22(1): 394-406 [PMID: 26755885 DOI: 10.3748/wjg.v22.i1.394] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
273 Kew MC. The role of cirrhosis in the etiology of hepatocellular carcinoma. J Gastrointest Cancer. 2014;45:12-21. [PMID: 24203525 DOI: 10.1007/s12029-013-9556-9] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.8] [Reference Citation Analysis]
274 Zhang J, Zhao Y, Ren D, Yang X. Effect of okra fruit powder supplementation on metabolic syndrome and gut microbiota diversity in high fat diet-induced obese mice. Food Res Int 2020;130:108929. [PMID: 32156377 DOI: 10.1016/j.foodres.2019.108929] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
275 Zhang W, Hou J, Wang X, Jiang R, Yin Y, Ji J, Deng L, Huang X, Wang K, Sun B. PTPRO-mediated autophagy prevents hepatosteatosis and tumorigenesis. Oncotarget. 2015;6:9420-9433. [PMID: 25826083 DOI: 10.18632/oncotarget.3353] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 2.7] [Reference Citation Analysis]
276 Rao S, Yang X, Ohshiro K, Zaidi S, Wang Z, Shetty K, Xiang X, Hassan MI, Mohammad T, Latham PS, Nguyen BN, Wong L, Yu H, Al-Abed Y, Mishra B, Vacca M, Guenigault G, Allison MED, Vidal-Puig A, Benhammou JN, Alvarez M, Pajukanta P, Pisegna JR, Mishra L. β2-spectrin (SPTBN1) as a therapeutic target for diet-induced liver disease and preventing cancer development. Sci Transl Med 2021;13:eabk2267. [PMID: 34910547 DOI: 10.1126/scitranslmed.abk2267] [Reference Citation Analysis]
277 Passman AM, Strauss RP, McSpadden SB, Finch-Edmondson M, Andrewartha N, Woo KH, Diepeveen LA, Zhao W, Fernández-Irigoyen J, Santamaría E, Medina-Ruiz L, Szpakowska M, Chevigné A, Park H, Carlessi R, Tirnitz-Parker JEE, Blanco JR, London R, Callus BA, Elsegood CL, Baker MV, Martínez A, Yeoh GCT, Ochoa-Callejero L. Maraviroc Prevents HCC Development by Suppressing Macrophages and the Liver Progenitor Cell Response in a Murine Chronic Liver Disease Model. Cancers (Basel) 2021;13:4935. [PMID: 34638423 DOI: 10.3390/cancers13194935] [Reference Citation Analysis]
278 Olatunde A, Nigam M, Singh RK, Panwar AS, Lasisi A, Alhumaydhi FA, Jyoti Kumar V, Mishra AP, Sharifi-Rad J. Cancer and diabetes: the interlinking metabolic pathways and repurposing actions of antidiabetic drugs. Cancer Cell Int 2021;21:499. [PMID: 34535145 DOI: 10.1186/s12935-021-02202-5] [Reference Citation Analysis]
279 Kolb R, Sutterwala FS, Zhang W. Obesity and cancer: inflammation bridges the two. Curr Opin Pharmacol 2016;29:77-89. [PMID: 27429211 DOI: 10.1016/j.coph.2016.07.005] [Cited by in Crossref: 100] [Cited by in F6Publishing: 101] [Article Influence: 16.7] [Reference Citation Analysis]
280 Shimizu M, Tanaka T, Moriwaki H. Obesity and hepatocellular carcinoma: targeting obesity-related inflammation for chemoprevention of liver carcinogenesis. Semin Immunopathol. 2013;35:191-202. [PMID: 22945457 DOI: 10.1007/s00281-012-0336-6] [Cited by in Crossref: 36] [Cited by in F6Publishing: 37] [Article Influence: 3.6] [Reference Citation Analysis]
281 Xu W, Yi M, Li Q, Zhou W, Cong W, Yang Y, Ning B, Yin C, Huang Z, Wang J, Qian H, Jiang C, Chen Y, Xia C, Wang H, Zhang X, Xie W. Perturbation of MicroRNA-370/Lin-28 homolog A/nuclear factor kappa B regulatory circuit contributes to the development of hepatocellular carcinoma: Xu, Yi, et al. Hepatology 2013;58:1977-91. [DOI: 10.1002/hep.26541] [Cited by in Crossref: 50] [Cited by in F6Publishing: 55] [Article Influence: 5.6] [Reference Citation Analysis]
282 Sui J, Yang W, Ma Y, Li TY, Simon TG, Meyerhardt JA, Liang G, Giovannucci EL, Chan AT, Zhang X. A Prospective Study of Nut Consumption and Risk of Primary Hepatocellular Carcinoma in the U.S. Women and Men. Cancer Prev Res (Phila) 2019;12:367-74. [PMID: 31040153 DOI: 10.1158/1940-6207.CAPR-18-0511] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
283 De Mattia E, Cecchin E, Polesel J, Bignucolo A, Roncato R, Lupo F, Crovatto M, Buonadonna A, Tiribelli C, Toffoli G. Genetic biomarkers for hepatocellular cancer risk in a caucasian population. World J Gastroenterol 2017; 23(36): 6674-6684 [PMID: 29085212 DOI: 10.3748/wjg.v23.i36.6674] [Cited by in CrossRef: 18] [Cited by in F6Publishing: 14] [Article Influence: 3.6] [Reference Citation Analysis]
284 Kobos L, Alqahtani S, Xia L, Coltellino V, Kishman R, McIlrath D, Perez-Torres C, Shannahan J. Comparison of silver nanoparticle-induced inflammatory responses between healthy and metabolic syndrome mouse models. J Toxicol Environ Health A 2020;83:249-68. [PMID: 32281499 DOI: 10.1080/15287394.2020.1748779] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
285 Włodarczyk M, Nowicka G. Obesity, DNA Damage, and Development of Obesity-Related Diseases. Int J Mol Sci 2019;20:E1146. [PMID: 30845725 DOI: 10.3390/ijms20051146] [Cited by in Crossref: 47] [Cited by in F6Publishing: 46] [Article Influence: 15.7] [Reference Citation Analysis]
286 Shi M, Jiang Y, Yang L, Yan S, Wang YG, Lu XJ. Decreased levels of serum exosomal miR-638 predict poor prognosis in hepatocellular carcinoma. J Cell Biochem. 2018;119:4711-4716. [PMID: 29278659 DOI: 10.1002/jcb.26650] [Cited by in Crossref: 64] [Cited by in F6Publishing: 69] [Article Influence: 16.0] [Reference Citation Analysis]
287 Cai X, Gan Y, Fan Y, Hu J, Jin Y, Chen F, Chen T, Sun Y, Wang J, Qin W, Tu H. The adiponectin gene single-nucleotide polymorphism rs1501299 is associated with hepatocellular carcinoma risk. Clin Transl Oncol 2014;16:166-72. [PMID: 23740135 DOI: 10.1007/s12094-013-1056-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
288 Chadid S, Kreger BE, Singer MR, Loring Bradlee M, Moore LL. Anthropometric measures of body fat and obesity-related cancer risk: sex-specific differences in Framingham Offspring Study adults. Int J Obes (Lond) 2020;44:601-8. [PMID: 31974408 DOI: 10.1038/s41366-020-0519-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
289 Petrick JL, Thistle JE, Zeleniuch-Jacquotte A, Zhang X, Wactawski-Wende J, Van Dyke AL, Stampfer MJ, Sinha R, Sesso HD, Schairer C, Rosenberg L, Rohan TE, Robien K, Purdue MP, Poynter JN, Palmer JR, Newton CC, Linet MS, Liao LM, Lee IM, Koshiol J, Kitahara CM, Hofmann JN, Graubard BI, Giovannucci E, Gaziano MJ, Gapstur SM, Freedman ND, Chong DQ, Chan AT, Buring JE, Freeman LBE, Campbell PT, McGlynn KA. Body Mass Index, Diabetes and Intrahepatic Cholangiocarcinoma Risk: The Liver Cancer Pooling Project and Meta-analysis. Am J Gastroenterol. 2018;113:1494-1505. [PMID: 30177781 DOI: 10.1038/s41395-018-0207-4] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 7.3] [Reference Citation Analysis]
290 Gholami M, Sharifi F, Shahriari S, Khoshnevisan K, Larijani B, Amoli MM. Association of interleukin-6 polymorphisms with obesity: A systematic review and meta-analysis. Cytokine 2019;123:154769. [PMID: 31472475 DOI: 10.1016/j.cyto.2019.154769] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]